JP2019517596A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517596A5 JP2019517596A5 JP2019517187A JP2019517187A JP2019517596A5 JP 2019517596 A5 JP2019517596 A5 JP 2019517596A5 JP 2019517187 A JP2019517187 A JP 2019517187A JP 2019517187 A JP2019517187 A JP 2019517187A JP 2019517596 A5 JP2019517596 A5 JP 2019517596A5
- Authority
- JP
- Japan
- Prior art keywords
- dicyano
- thio
- phenylacetamide
- amino
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 230
- -1 -OR e Chemical group 0.000 claims 167
- 125000001424 substituent group Chemical group 0.000 claims 132
- 235000019000 fluorine Nutrition 0.000 claims 131
- 229910052731 fluorine Inorganic materials 0.000 claims 130
- 239000011737 fluorine Substances 0.000 claims 130
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 129
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 89
- 125000000753 cycloalkyl group Chemical group 0.000 claims 85
- 125000003118 aryl group Chemical group 0.000 claims 75
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 69
- 229910052801 chlorine Inorganic materials 0.000 claims 69
- 239000000460 chlorine Substances 0.000 claims 69
- 125000004093 cyano group Chemical group *C#N 0.000 claims 69
- 125000001072 heteroaryl group Chemical group 0.000 claims 67
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 58
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 52
- 125000003545 alkoxy group Chemical group 0.000 claims 48
- 125000004043 oxo group Chemical group O=* 0.000 claims 39
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 35
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 32
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 32
- 229910052794 bromium Inorganic materials 0.000 claims 32
- 150000001875 compounds Chemical class 0.000 claims 30
- 239000008194 pharmaceutical composition Substances 0.000 claims 30
- 150000003839 salts Chemical class 0.000 claims 27
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 24
- 125000003566 oxetanyl group Chemical group 0.000 claims 21
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 20
- 229910052739 hydrogen Inorganic materials 0.000 claims 17
- 239000001257 hydrogen Substances 0.000 claims 17
- 125000002883 imidazolyl group Chemical group 0.000 claims 17
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 17
- 206010028980 Neoplasm Diseases 0.000 claims 16
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 16
- 125000003386 piperidinyl group Chemical group 0.000 claims 16
- 241000124008 Mammalia Species 0.000 claims 15
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 claims 15
- 229910052757 nitrogen Inorganic materials 0.000 claims 14
- 201000011510 cancer Diseases 0.000 claims 13
- 229940002612 prodrug Drugs 0.000 claims 12
- 239000000651 prodrug Substances 0.000 claims 12
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 12
- 125000002393 azetidinyl group Chemical group 0.000 claims 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 11
- 125000004193 piperazinyl group Chemical group 0.000 claims 11
- 125000003226 pyrazolyl group Chemical group 0.000 claims 11
- 125000002785 azepinyl group Chemical group 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
- 150000002431 hydrogen Chemical class 0.000 claims 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 10
- 208000007056 sickle cell anemia Diseases 0.000 claims 10
- 229910052717 sulfur Inorganic materials 0.000 claims 10
- 201000010099 disease Diseases 0.000 claims 9
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 208000011580 syndromic disease Diseases 0.000 claims 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 7
- 125000005842 heteroatom Chemical group 0.000 claims 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 7
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 7
- RKAYIEFADPAEOO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=CC=C1 RKAYIEFADPAEOO-UHFFFAOYSA-N 0.000 claims 6
- LNEBGQBVQRBDMK-UHFFFAOYSA-N 2-[6-(4-amino-4-methylpiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C LNEBGQBVQRBDMK-UHFFFAOYSA-N 0.000 claims 6
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims 6
- 208000006402 Ductal Carcinoma Diseases 0.000 claims 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 6
- 208000005017 glioblastoma Diseases 0.000 claims 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 6
- 125000002757 morpholinyl group Chemical group 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
- 230000002159 abnormal effect Effects 0.000 claims 5
- 208000009956 adenocarcinoma Diseases 0.000 claims 5
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 5
- 125000006311 cyclobutyl amino group Chemical group [H]N(*)C1([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 5
- 125000000160 oxazolidinyl group Chemical group 0.000 claims 5
- 150000003852 triazoles Chemical class 0.000 claims 5
- AYZZJIDLBKXRKQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[2-(hydroxymethyl)morpholin-4-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(OCC1)CO)SC(C(=O)N)C1=CC=CC=C1 AYZZJIDLBKXRKQ-UHFFFAOYSA-N 0.000 claims 4
- QVROPBZLGMQZIH-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[3-(dimethylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(CCC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 QVROPBZLGMQZIH-UHFFFAOYSA-N 0.000 claims 4
- JZULSOHKMKJPIN-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=CC=C(C=C1)F JZULSOHKMKJPIN-UHFFFAOYSA-N 0.000 claims 4
- AYNULTGWVKTAEP-UHFFFAOYSA-N 2-[6-(3-aminoazetidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N AYNULTGWVKTAEP-UHFFFAOYSA-N 0.000 claims 4
- QNAWNFWIFHMERM-UHFFFAOYSA-N 2-[6-[(2-amino-2-oxoethyl)-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C)=O QNAWNFWIFHMERM-UHFFFAOYSA-N 0.000 claims 4
- CWUNMSSHZVRHPS-UHFFFAOYSA-N 2-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]ethyl dihydrogen phosphate Chemical compound P(=O)(OCCN(C)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(O)O CWUNMSSHZVRHPS-UHFFFAOYSA-N 0.000 claims 4
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 4
- 206010068873 Adenosquamous cell carcinoma Diseases 0.000 claims 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 4
- 206010018404 Glucagonoma Diseases 0.000 claims 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-Valine Natural products CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 4
- 208000018020 Sickle cell-beta-thalassemia disease syndrome Diseases 0.000 claims 4
- 206010043391 Thalassaemia beta Diseases 0.000 claims 4
- 208000006336 acinar cell carcinoma Diseases 0.000 claims 4
- 201000008395 adenosquamous carcinoma Diseases 0.000 claims 4
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims 4
- 208000034737 hemoglobinopathy Diseases 0.000 claims 4
- 239000003112 inhibitor Substances 0.000 claims 4
- 206010022498 insulinoma Diseases 0.000 claims 4
- 208000032839 leukemia Diseases 0.000 claims 4
- 201000001441 melanoma Diseases 0.000 claims 4
- NJYYWQHQUOODDL-UHFFFAOYSA-N oxetane-3-carboxamide Chemical compound NC(=O)C1COC1 NJYYWQHQUOODDL-UHFFFAOYSA-N 0.000 claims 4
- 208000021255 pancreatic insulinoma Diseases 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 claims 4
- TWLBWWRTVQHOCK-RDTXWAMCSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3R)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CC1)O)S[C@@H](C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-RDTXWAMCSA-N 0.000 claims 3
- TWLBWWRTVQHOCK-KBXCAEBGSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)S[C@@H](C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-KBXCAEBGSA-N 0.000 claims 3
- TWLBWWRTVQHOCK-KSSFIOAISA-N (2S)-2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)S[C@H](C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-KSSFIOAISA-N 0.000 claims 3
- WUVHZNRMARLTQL-UHFFFAOYSA-N 2-[3,5-dicyano-4-(furan-2-yl)-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C=1OC=CC=1)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=CC=C1 WUVHZNRMARLTQL-UHFFFAOYSA-N 0.000 claims 3
- TWLBWWRTVQHOCK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(3-hydroxypyrrolidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CC1)O)SC(C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-UHFFFAOYSA-N 0.000 claims 3
- TWLBWWRTVQHOCK-IKJXHCRLSA-N 2-[3,5-dicyano-4-ethyl-6-[(3R)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-IKJXHCRLSA-N 0.000 claims 3
- TWLBWWRTVQHOCK-PIVQAISJSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 TWLBWWRTVQHOCK-PIVQAISJSA-N 0.000 claims 3
- 206010003571 Astrocytoma Diseases 0.000 claims 3
- 208000012609 Cowden disease Diseases 0.000 claims 3
- 201000002847 Cowden syndrome Diseases 0.000 claims 3
- 208000032612 Glial tumor Diseases 0.000 claims 3
- 201000010915 Glioblastoma multiforme Diseases 0.000 claims 3
- 206010018338 Glioma Diseases 0.000 claims 3
- 208000008770 Multiple Hamartoma Syndrome Diseases 0.000 claims 3
- 206010039491 Sarcoma Diseases 0.000 claims 3
- 210000004556 brain Anatomy 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 125000006317 cyclopropyl amino group Chemical group 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 210000003128 head Anatomy 0.000 claims 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 3
- 210000003734 kidney Anatomy 0.000 claims 3
- 210000004185 liver Anatomy 0.000 claims 3
- 210000003739 neck Anatomy 0.000 claims 3
- 210000001672 ovary Anatomy 0.000 claims 3
- 210000000496 pancreas Anatomy 0.000 claims 3
- 210000002307 prostate Anatomy 0.000 claims 3
- 210000001685 thyroid gland Anatomy 0.000 claims 3
- 125000001425 triazolyl group Chemical group 0.000 claims 3
- CITLODUGFLYYPD-GOSISDBHSA-N (2R)-2-(3,5-dicyano-4-ethyl-6-morpholin-4-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCOCC1)S[C@@H](C(=O)N)C1=CC=CC=C1 CITLODUGFLYYPD-GOSISDBHSA-N 0.000 claims 2
- XBGYNCRALWAEIG-HSZRJFAPSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-(4-pyrrolidin-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCCC1)S[C@@H](C(=O)N)C1=CC=CC=C1 XBGYNCRALWAEIG-HSZRJFAPSA-N 0.000 claims 2
- YFYRJDAXIJWXRZ-IIBYNOLFSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(2R)-2-[[(2-hydroxyacetyl)amino]methyl]morpholin-4-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC([C@@H](C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1C[C@H](OCC1)CNC(CO)=O)C#N)CC)C#N)=O YFYRJDAXIJWXRZ-IIBYNOLFSA-N 0.000 claims 2
- NAXQRMHGLARATP-XMSQKQJNSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3R)-3-hydroxy-3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@](CC1)(CO)O)S[C@@H](C(=O)N)C1=CC=CC=C1 NAXQRMHGLARATP-XMSQKQJNSA-N 0.000 claims 2
- NAXQRMHGLARATP-GCJKJVERSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxy-3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@](CC1)(CO)O)S[C@@H](C(=O)N)C1=CC=CC=C1 NAXQRMHGLARATP-GCJKJVERSA-N 0.000 claims 2
- LACBFVVSYQHECW-KPZWWZAWSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2,4-difluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)S[C@@H](C(=O)N)C1=C(C=C(C=C1)F)F LACBFVVSYQHECW-KPZWWZAWSA-N 0.000 claims 2
- XOYGSTAJAGOUHB-QGZVFWFLSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[2-hydroxyethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCO)S[C@@H](C(=O)N)C1=CC=CC=C1 XOYGSTAJAGOUHB-QGZVFWFLSA-N 0.000 claims 2
- SEPYRSOYBZMXCN-GOSISDBHSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[3-hydroxypropyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCCO)S[C@@H](C(=O)N)C1=CC=CC=C1 SEPYRSOYBZMXCN-GOSISDBHSA-N 0.000 claims 2
- KYIDEMYYLVDDEB-DNVCBOLYSA-N (2R)-2-[3,5-dicyano-4-ethyl-6-[methyl-[(3R)-oxolan-3-yl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N([C@H]1COCC1)C)S[C@@H](C(=O)N)C1=CC=CC=C1 KYIDEMYYLVDDEB-DNVCBOLYSA-N 0.000 claims 2
- KIEQQZZDWUNUQK-MRXNPFEDSA-N (2R)-2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)S[C@@H](C(=O)N)C1=CC=CC=C1 KIEQQZZDWUNUQK-MRXNPFEDSA-N 0.000 claims 2
- MELQQCMEXPGRLW-OAQYLSRUSA-N (2R)-2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)S[C@@H](C(=O)N)C1=CC=CC=C1 MELQQCMEXPGRLW-OAQYLSRUSA-N 0.000 claims 2
- KNKHRZYILDZLRE-LJQANCHMSA-N (2R)-2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KNKHRZYILDZLRE-LJQANCHMSA-N 0.000 claims 2
- PMWNNSZNZVXNKL-DNVCBOLYSA-N (2R)-2-[6-[(2R)-2-(aminomethyl)morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@H]1OCCN(C1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PMWNNSZNZVXNKL-DNVCBOLYSA-N 0.000 claims 2
- XUJZHDXEUODIPV-XMSQKQJNSA-N (2R)-2-[6-[(3R)-3-(aminomethyl)-3-hydroxypyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@]1(CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O XUJZHDXEUODIPV-XMSQKQJNSA-N 0.000 claims 2
- PXKHEPMNNUEAGS-GUDVDZBRSA-N (2R)-2-[6-[(3R,4R)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-GUDVDZBRSA-N 0.000 claims 2
- QISXCBQMUSSXPW-GUDVDZBRSA-N (2R)-2-[6-[(3R,4R)-4-amino-3-hydroxypiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O QISXCBQMUSSXPW-GUDVDZBRSA-N 0.000 claims 2
- PXKHEPMNNUEAGS-CEXWTWQISA-N (2R)-2-[6-[(3R,4S)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1[C@@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-CEXWTWQISA-N 0.000 claims 2
- SLFVOEJIFPFHPQ-GCJKJVERSA-N (2R)-2-[6-[(3S)-3-(aminomethyl)-3-fluoropyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@@]1(CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F SLFVOEJIFPFHPQ-GCJKJVERSA-N 0.000 claims 2
- XUJZHDXEUODIPV-GCJKJVERSA-N (2R)-2-[6-[(3S)-3-(aminomethyl)-3-hydroxypyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@@]1(CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O XUJZHDXEUODIPV-GCJKJVERSA-N 0.000 claims 2
- PXKHEPMNNUEAGS-IPMKNSEASA-N (2R)-2-[6-[(3S,4R)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-IPMKNSEASA-N 0.000 claims 2
- QISXCBQMUSSXPW-CEXWTWQISA-N (2R)-2-[6-[(3S,4R)-4-amino-3-hydroxypiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O QISXCBQMUSSXPW-CEXWTWQISA-N 0.000 claims 2
- PXKHEPMNNUEAGS-GBESFXJTSA-N (2R)-2-[6-[(3S,4S)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1[C@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-GBESFXJTSA-N 0.000 claims 2
- RJMRXCDNOIGHBN-OAQYLSRUSA-N (2R)-2-[[3,5-dicyano-4-ethyl-6-(4-ethyl-1,4-diazepan-1-yl)pyridin-2-yl]amino]-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CC)N[C@@H](C(=O)N)C1=CC=CC=C1 RJMRXCDNOIGHBN-OAQYLSRUSA-N 0.000 claims 2
- DXUKXJSINKNGTD-OAQYLSRUSA-N (2R)-2-[[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]amino]-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCO)N[C@@H](C(=O)N)C1=CC=CC=C1 DXUKXJSINKNGTD-OAQYLSRUSA-N 0.000 claims 2
- SEKLCRJQUCYDPG-AREMUKBSSA-N (2R)-2-[[3,5-dicyano-4-ethyl-6-[4-(3-pyrrolidin-1-ylpropyl)-1,4-diazepan-1-yl]pyridin-2-yl]amino]-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCCN1CCCC1)N[C@@H](C(=O)N)C1=CC=CC=C1 SEKLCRJQUCYDPG-AREMUKBSSA-N 0.000 claims 2
- HSKVBTYMHPVTJH-LJQANCHMSA-N (2R)-2-[[3,5-dicyano-6-(1,4-diazepan-1-yl)-4-ethylpyridin-2-yl]amino]-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCCC1)N[C@@H](C(=O)N)C1=CC=CC=C1 HSKVBTYMHPVTJH-LJQANCHMSA-N 0.000 claims 2
- OKWMELWZORVWFL-QSVWIEALSA-N (2R)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]azetidin-3-yl]-3-hydroxypropanamide Chemical compound N[C@@H](C(=O)NC1CN(C1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)CO OKWMELWZORVWFL-QSVWIEALSA-N 0.000 claims 2
- YGJJZMSBZVUVKQ-JGHKVMFLSA-N (2R)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]piperidin-4-yl]propanamide Chemical compound N[C@@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)C YGJJZMSBZVUVKQ-JGHKVMFLSA-N 0.000 claims 2
- UKIZLJJTXDLHOT-VQCQRNETSA-N (2R)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]-3-hydroxypropanamide Chemical compound N[C@@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)CO UKIZLJJTXDLHOT-VQCQRNETSA-N 0.000 claims 2
- ZKTQBLPUIOTRRR-RBFZIWAESA-N (2R)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]propanamide Chemical compound N[C@@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)C ZKTQBLPUIOTRRR-RBFZIWAESA-N 0.000 claims 2
- KIEQQZZDWUNUQK-QKHLJXARSA-N (2R)-2-deuterio-2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)S[C@](C(=O)N)([2H])C1=CC=CC=C1 KIEQQZZDWUNUQK-QKHLJXARSA-N 0.000 claims 2
- KYIDEMYYLVDDEB-BEFAXECRSA-N (2S)-2-[3,5-dicyano-4-ethyl-6-[methyl-[(3R)-oxolan-3-yl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N([C@H]1COCC1)C)S[C@H](C(=O)N)C1=CC=CC=C1 KYIDEMYYLVDDEB-BEFAXECRSA-N 0.000 claims 2
- KNKHRZYILDZLRE-IBGZPJMESA-N (2S)-2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)S[C@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KNKHRZYILDZLRE-IBGZPJMESA-N 0.000 claims 2
- PXKHEPMNNUEAGS-QYZOEREBSA-N (2S)-2-[6-[(3R,4S)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1[C@@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-QYZOEREBSA-N 0.000 claims 2
- PXKHEPMNNUEAGS-OTWHNJEPSA-N (2S)-2-[6-[(3S,4R)-4-amino-3-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1[C@H](CN(CC1)C1=C(C(=C(C(=N1)S[C@H](C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F PXKHEPMNNUEAGS-OTWHNJEPSA-N 0.000 claims 2
- OKWMELWZORVWFL-LROBGIAVSA-N (2S)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]azetidin-3-yl]-3-hydroxypropanamide Chemical compound N[C@H](C(=O)NC1CN(C1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)CO OKWMELWZORVWFL-LROBGIAVSA-N 0.000 claims 2
- YGJJZMSBZVUVKQ-UEDXYCIISA-N (2S)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]piperidin-4-yl]propanamide Chemical compound N[C@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)C YGJJZMSBZVUVKQ-UEDXYCIISA-N 0.000 claims 2
- UKIZLJJTXDLHOT-BGERDNNASA-N (2S)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]-3-hydroxypropanamide Chemical compound N[C@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)CO UKIZLJJTXDLHOT-BGERDNNASA-N 0.000 claims 2
- ZKTQBLPUIOTRRR-ZDGMYTEDSA-N (2S)-2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]propanamide Chemical compound N[C@H](C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)C ZKTQBLPUIOTRRR-ZDGMYTEDSA-N 0.000 claims 2
- ITEPIAUQBCBCAW-UHFFFAOYSA-N 1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-4-hydroxypiperidine-4-carboxamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)(C(=O)N)O)C#N)CC)C#N)=O ITEPIAUQBCBCAW-UHFFFAOYSA-N 0.000 claims 2
- JLJIZFOSRBABJL-UHFFFAOYSA-N 1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidine-4-carboxamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)C(=O)N)C#N)CC)C#N)=O JLJIZFOSRBABJL-UHFFFAOYSA-N 0.000 claims 2
- DUJZKRZORJLCLM-UHFFFAOYSA-N 1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]pyrrolidine-3-carboxamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CC(CC1)C(=O)N)C#N)CC)C#N)=O DUJZKRZORJLCLM-UHFFFAOYSA-N 0.000 claims 2
- KYURKRFGKGRNNG-UHFFFAOYSA-N 2-(3,5-dichloro-4-ethyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound ClC=1C(=NC(=C(C=1CC)Cl)N1CCNCC1)SC(C(=O)N)C1=CC=CC=C1 KYURKRFGKGRNNG-UHFFFAOYSA-N 0.000 claims 2
- DHNDYNWUHXEKBW-UHFFFAOYSA-N 2-(3,5-dicyano-4,6-diethylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)CC)SC(C(=O)N)C1=CC=CC=C1 DHNDYNWUHXEKBW-UHFFFAOYSA-N 0.000 claims 2
- AFWBPDSPAKJTII-UHFFFAOYSA-N 2-(3,5-dicyano-4-cyclopropyl-6-morpholin-4-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 AFWBPDSPAKJTII-UHFFFAOYSA-N 0.000 claims 2
- VMDVTANOJNOWGA-UHFFFAOYSA-N 2-(3,5-dicyano-4-cyclopropyl-6-morpholin-4-ylpyridin-2-yl)sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCOCC1)SC(C(=O)N)C1=CC=NC=C1 VMDVTANOJNOWGA-UHFFFAOYSA-N 0.000 claims 2
- JEEKMGZTZSORLV-UHFFFAOYSA-N 2-(3,5-dicyano-4-cyclopropyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNCC1)SC(C(=O)N)C1=CC=NC=C1 JEEKMGZTZSORLV-UHFFFAOYSA-N 0.000 claims 2
- ZLCZVATZPMXDKH-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethoxy-6-methylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCC)C#N)C)SC(C(=O)N)C1=CC=CC=C1 ZLCZVATZPMXDKH-UHFFFAOYSA-N 0.000 claims 2
- JSCBRTMDYAZVCC-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-methylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)C)SC(C(=O)N)C1=CC=CC=C1 JSCBRTMDYAZVCC-UHFFFAOYSA-N 0.000 claims 2
- CITLODUGFLYYPD-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-morpholin-4-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 CITLODUGFLYYPD-UHFFFAOYSA-N 0.000 claims 2
- VEEUARNCRSRLMI-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCC1)SC(C(=O)N)C1=CC=C(C=C1)F VEEUARNCRSRLMI-UHFFFAOYSA-N 0.000 claims 2
- ZWCZXCXGYPKPTE-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCC1)SC(C(=O)N)C1=CC=CC=C1 ZWCZXCXGYPKPTE-UHFFFAOYSA-N 0.000 claims 2
- QKTOMHMXAKONNE-UHFFFAOYSA-N 2-(3,5-dicyano-4-ethyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-thiophen-3-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCC1)SC(C(=O)N)C1=CSC=C1 QKTOMHMXAKONNE-UHFFFAOYSA-N 0.000 claims 2
- JWWLGAVPWYJCBJ-UHFFFAOYSA-N 2-(3-benzoylphenyl)-2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanylacetamide Chemical compound C(C1=CC=CC=C1)(=O)C=1C=C(C=CC=1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N1CCN(CCC1)CCO JWWLGAVPWYJCBJ-UHFFFAOYSA-N 0.000 claims 2
- XZSDQGMQWFSLJW-UHFFFAOYSA-N 2-(3-cyano-4-ethyl-5-methyl-6-piperazin-1-ylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C)N1CCNCC1)SC(C(=O)N)C1=CC=CC=C1 XZSDQGMQWFSLJW-UHFFFAOYSA-N 0.000 claims 2
- PTQOINFPPNUTEJ-UHFFFAOYSA-N 2-(4-benzoylphenyl)-2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanylacetamide Chemical compound C(C1=CC=CC=C1)(=O)C1=CC=C(C=C1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N1CCN(CCC1)CCO PTQOINFPPNUTEJ-UHFFFAOYSA-N 0.000 claims 2
- STOCLPJPNSTUAB-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanylacetamide Chemical compound ClC1=CC=C(C=C1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N(C)C STOCLPJPNSTUAB-UHFFFAOYSA-N 0.000 claims 2
- BIKGIIMWQRGVJH-UHFFFAOYSA-N 2-[3,5-dichloro-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound ClC=1C(=NC(=C(C=1CC)Cl)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=CC=C1 BIKGIIMWQRGVJH-UHFFFAOYSA-N 0.000 claims 2
- RXFPUVXNVRCHKD-UHFFFAOYSA-N 2-[3,5-dichloro-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound ClC=1C(=NC(=C(C=1CC)Cl)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 RXFPUVXNVRCHKD-UHFFFAOYSA-N 0.000 claims 2
- PAUHBDXOZUTHBS-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNCCC1)SC(C(=O)N)C1=CC=CC=C1 PAUHBDXOZUTHBS-UHFFFAOYSA-N 0.000 claims 2
- WPLNPAJJUPRGNG-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNCCC1)SC(C(=O)N)C1=CC=NC=C1 WPLNPAJJUPRGNG-UHFFFAOYSA-N 0.000 claims 2
- UUOZMGVKHLFJBA-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(1,4-diazepan-1-yl)pyridin-2-yl]sulfanylpropanamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNCCC1)SC(C(=O)N)C UUOZMGVKHLFJBA-UHFFFAOYSA-N 0.000 claims 2
- IYEHEHCKPMJGMI-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(2,6-dimethylmorpholin-4-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(OC(C1)C)C)SC(C(=O)N)C1=CC=CC=C1 IYEHEHCKPMJGMI-UHFFFAOYSA-N 0.000 claims 2
- JPVHKFLIWFESRW-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-hydroxyazetidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(C1)O)SC(C(=O)N)C1=CC=CC=C1 JPVHKFLIWFESRW-UHFFFAOYSA-N 0.000 claims 2
- WZQFJKWYRNLKDK-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-hydroxypiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(CCC1)O)SC(C(=O)N)C1=CC=CC=C1 WZQFJKWYRNLKDK-UHFFFAOYSA-N 0.000 claims 2
- KSEUXNSAPLLRCN-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-hydroxypyrrolidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(CC1)O)SC(C(=O)N)C1=CC=CC=C1 KSEUXNSAPLLRCN-UHFFFAOYSA-N 0.000 claims 2
- RKGZAWAZEJZLRD-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-methylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(NCC1)C)SC(C(=O)N)C1=CC=CC=C1 RKGZAWAZEJZLRD-UHFFFAOYSA-N 0.000 claims 2
- GSMZCJKTZVHVCP-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(3-oxopiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(NCC1)=O)SC(C(=O)N)C1=CC=CC=C1 GSMZCJKTZVHVCP-UHFFFAOYSA-N 0.000 claims 2
- IPIAHZTYERRXQS-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(4-ethyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCN(CCC1)CC)SC(C(=O)N)C1=CC=CC=C1 IPIAHZTYERRXQS-UHFFFAOYSA-N 0.000 claims 2
- IWCAZNGYRSJFIX-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(4-methyl-5-oxo-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCN(C(CC1)=O)C)SC(C(=O)N)C1=CC=CC=C1 IWCAZNGYRSJFIX-UHFFFAOYSA-N 0.000 claims 2
- MHUDTXOVWMDNQJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(4-morpholin-4-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)N1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 MHUDTXOVWMDNQJ-UHFFFAOYSA-N 0.000 claims 2
- SMKAEMALCGLLMQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(4-pyrrolidin-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)N1CCCC1)SC(C(=O)N)C1=CC=CC=C1 SMKAEMALCGLLMQ-UHFFFAOYSA-N 0.000 claims 2
- BBCJAXNYDGYRPG-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(5-oxo-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCNC(CC1)=O)SC(C(=O)N)C1=CC=CC=C1 BBCJAXNYDGYRPG-UHFFFAOYSA-N 0.000 claims 2
- SQSPRRWZSIZYKO-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(dimethylamino)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N(C)C)SC(C(=O)N)C1=CC=CC=C1 SQSPRRWZSIZYKO-UHFFFAOYSA-N 0.000 claims 2
- UEXXHPWRYIUMFR-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-(dimethylamino)pyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N(C)C)SC(C(=O)N)C1=CC=NC=C1 UEXXHPWRYIUMFR-UHFFFAOYSA-N 0.000 claims 2
- WZQFJKWYRNLKDK-QRIPLOBPSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[(3R)-3-hydroxypiperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1C[C@@H](CCC1)O)SC(C(=O)N)C1=CC=CC=C1 WZQFJKWYRNLKDK-QRIPLOBPSA-N 0.000 claims 2
- WZQFJKWYRNLKDK-DJZRFWRSSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[(3S)-3-hydroxypiperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1C[C@H](CCC1)O)SC(C(=O)N)C1=CC=CC=C1 WZQFJKWYRNLKDK-DJZRFWRSSA-N 0.000 claims 2
- SQIPHLMGNXRJAF-PIVQAISJSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC=NC=C1 SQIPHLMGNXRJAF-PIVQAISJSA-N 0.000 claims 2
- JJLWDWRURXASKJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[2-hydroxyethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N(C)CCO)SC(C(=O)N)C1=CC=CC=C1 JJLWDWRURXASKJ-UHFFFAOYSA-N 0.000 claims 2
- VRKPCWYOSROMON-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[3-(hydroxymethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(NCC1)CO)SC(C(=O)N)C1=CC=CC=C1 VRKPCWYOSROMON-UHFFFAOYSA-N 0.000 claims 2
- MTKDQKSITHIDHV-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[3-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CC(CCC1)NC)SC(C(=O)N)C1=CC=CC=C1 MTKDQKSITHIDHV-UHFFFAOYSA-N 0.000 claims 2
- UIELGJHJGGLZRH-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-(2-hydroxyethylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)NCCO)SC(C(=O)N)C1=CC=CC=C1 UIELGJHJGGLZRH-UHFFFAOYSA-N 0.000 claims 2
- KNBHJJWOMHZEDQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)N1CCN(CC1)C)SC(C(=O)N)C1=CC=CC=C1 KNBHJJWOMHZEDQ-UHFFFAOYSA-N 0.000 claims 2
- DQOICBVYYITCQG-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-(dimethylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 DQOICBVYYITCQG-UHFFFAOYSA-N 0.000 claims 2
- KGRZKCREFYCZIS-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-(pyrrolidin-1-ylmethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)CN1CCCC1)SC(C(=O)N)C1=CC=CC=C1 KGRZKCREFYCZIS-UHFFFAOYSA-N 0.000 claims 2
- FTKCQZIZGOMSAJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[4-[(4-methylpiperazin-1-yl)methyl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N1CCC(CC1)CN1CCN(CC1)C)SC(C(=O)N)C1=CC=CC=C1 FTKCQZIZGOMSAJ-UHFFFAOYSA-N 0.000 claims 2
- GPDJMEHJOIYQIE-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[[2-(1,3-dihydroxypropan-2-ylamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NC(CO)CO)C)C#N)C1CC1)C#N)=O GPDJMEHJOIYQIE-UHFFFAOYSA-N 0.000 claims 2
- WYWXZWWQTUQOHY-UHFFFAOYSA-N 2-[3,5-dicyano-4-cyclopropyl-6-[[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1C1CC1)C#N)N(C)CC(=O)N1CC(C1)O)SC(C(=O)N)C1=CC=CC=C1 WYWXZWWQTUQOHY-UHFFFAOYSA-N 0.000 claims 2
- LLVIJRJBWSAQNJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethoxy-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 LLVIJRJBWSAQNJ-UHFFFAOYSA-N 0.000 claims 2
- ORMVGEMLQLEGQS-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethoxy-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanylpropanamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C ORMVGEMLQLEGQS-UHFFFAOYSA-N 0.000 claims 2
- MPBQEERZVDUNNN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(1-oxa-7-azaspiro[3.4]octan-7-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2(CCO2)CC1)SC(C(=O)N)C1=CC=CC=C1 MPBQEERZVDUNNN-UHFFFAOYSA-N 0.000 claims 2
- PRTNICOWHDVOMU-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2=C(CC1)NN=N2)SC(C(=O)N)C1=CC=CC=C1 PRTNICOWHDVOMU-UHFFFAOYSA-N 0.000 claims 2
- GJXGSRAPRAPLIX-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-methyl-2,8-diazaspiro[4.5]decan-8-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCN(C2)C)CC1)SC(C(=O)N)C1=CC=CC=C1 GJXGSRAPRAPLIX-UHFFFAOYSA-N 0.000 claims 2
- DPLBLXGKZFRVOF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-methyl-2,9-diazaspiro[5.5]undecan-9-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCCN(C2)C)CC1)SC(C(=O)N)C1=CC=CC=C1 DPLBLXGKZFRVOF-UHFFFAOYSA-N 0.000 claims 2
- LCVVLDODJWARPO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-morpholin-4-ylethylsulfanyl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)SCCN1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 LCVVLDODJWARPO-UHFFFAOYSA-N 0.000 claims 2
- KXVNYMOJYHKQRG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-oxa-7-azaspiro[3.4]octan-7-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2(COC2)CC1)SC(C(=O)N)C1=CC=CC=C1 KXVNYMOJYHKQRG-UHFFFAOYSA-N 0.000 claims 2
- OUSMOLFOVYHQSJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CNC(O2)=O)CC1)SC(C(=O)N)C1=CC=CC=C1 OUSMOLFOVYHQSJ-UHFFFAOYSA-N 0.000 claims 2
- FFMZQDFWORDQBK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(2-oxo-3-oxa-1,8-diazaspiro[4.5]decan-8-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(COC(N2)=O)CC1)SC(C(=O)N)C1=CC=CC=C1 FFMZQDFWORDQBK-UHFFFAOYSA-N 0.000 claims 2
- UVYKEQNHOAEAFR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(3-hydroxyazetidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C1)O)SC(C(=O)N)C1=CC=CC=C1 UVYKEQNHOAEAFR-UHFFFAOYSA-N 0.000 claims 2
- JXAUMWOTJFLYOC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(3-methoxyazetidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C1)OC)SC(C(=O)N)C1=CC=CC=C1 JXAUMWOTJFLYOC-UHFFFAOYSA-N 0.000 claims 2
- MLKKPDGYCFASPL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(3-oxopiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(NCC1)=O)SC(C(=O)N)C1=CC=CC=C1 MLKKPDGYCFASPL-UHFFFAOYSA-N 0.000 claims 2
- AVLOZCTUBSLSSQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-ethyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CC)SC(C(=O)N)C1=CC=CC=C1 AVLOZCTUBSLSSQ-UHFFFAOYSA-N 0.000 claims 2
- AAPJDNZBMDEKFD-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-ethylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC)SC(C(=O)N)C1=CC=CC=C1 AAPJDNZBMDEKFD-UHFFFAOYSA-N 0.000 claims 2
- MZWZOPMPMLVLSG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-hydroxypiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)O)SC(C(=O)N)C1=CC=CC=C1 MZWZOPMPMLVLSG-UHFFFAOYSA-N 0.000 claims 2
- INRBWUZLUYKOMW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-imidazol-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(C=NC=C1)C1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N INRBWUZLUYKOMW-UHFFFAOYSA-N 0.000 claims 2
- CJPHXICXEMPGBK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-(2,5-difluoropyridin-4-yl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC(=NC=C1F)F CJPHXICXEMPGBK-UHFFFAOYSA-N 0.000 claims 2
- ITJZKPALGDQSHW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-(3-pyrrolidin-1-ylphenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC(=CC=C1)N1CCCC1 ITJZKPALGDQSHW-UHFFFAOYSA-N 0.000 claims 2
- FNVUXBZITHSRAB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-[3-(trifluoromethyl)phenyl]acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC(=CC=C1)C(F)(F)F FNVUXBZITHSRAB-UHFFFAOYSA-N 0.000 claims 2
- OGKOHDZLDNFFAB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-[4-(trifluoromethyl)phenyl]acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=C(C=C1)C(F)(F)F OGKOHDZLDNFFAB-UHFFFAOYSA-N 0.000 claims 2
- XRKVILGXGOHWOA-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-3-oxopiperazin-1-yl)pyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(N(CC1)C)=O)SC(C(=O)N)C1=CC=NC=C1 XRKVILGXGOHWOA-UHFFFAOYSA-N 0.000 claims 2
- AWDGEAGAQJZCNC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-methyl-5-oxo-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(C(CC1)=O)C)SC(C(=O)N)C1=CC=CC=C1 AWDGEAGAQJZCNC-UHFFFAOYSA-N 0.000 claims 2
- WHHWWBOLJJWTFW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-morpholin-4-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCOCC1)SC(C(=O)N)C1=CC=CC=C1 WHHWWBOLJJWTFW-UHFFFAOYSA-N 0.000 claims 2
- ZSYCORUQBBRZST-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-oxopiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)=O)SC(C(=O)N)C1=CC=CC=C1 ZSYCORUQBBRZST-UHFFFAOYSA-N 0.000 claims 2
- SHZQMUGRDNKXPI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-piperidin-4-ylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)C1CCNCC1)SC(C(=O)N)C1=CC=CC=C1 SHZQMUGRDNKXPI-UHFFFAOYSA-N 0.000 claims 2
- SBQYYTLFKRYESN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-piperidin-4-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(CCC(CC1)C1CCNCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N SBQYYTLFKRYESN-UHFFFAOYSA-N 0.000 claims 2
- ADKADAJBRJLLDR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-propyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCC)SC(C(=O)N)C1=CC=CC=C1 ADKADAJBRJLLDR-UHFFFAOYSA-N 0.000 claims 2
- BXSOWNMNUBXYQU-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-propylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CCC)SC(C(=O)N)C1=CC=CC=C1 BXSOWNMNUBXYQU-UHFFFAOYSA-N 0.000 claims 2
- XYFVYDXBONPTKL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-propylsulfonylpiperazin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)S(=O)(=O)CCC)SC(C(=O)N)C1=CC=CC=C1 XYFVYDXBONPTKL-UHFFFAOYSA-N 0.000 claims 2
- HRPNGMXDWIEOMY-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-pyrrolidin-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCCC1)SC(C(=O)N)C1=CC=C(C=C1)F HRPNGMXDWIEOMY-UHFFFAOYSA-N 0.000 claims 2
- XBGYNCRALWAEIG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-pyrrolidin-1-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCCC1)SC(C(=O)N)C1=CC=CC=C1 XBGYNCRALWAEIG-UHFFFAOYSA-N 0.000 claims 2
- MSLAJOMOZIQQLT-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(4-pyrrolidin-3-ylpiperidin-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)C1CNCC1)SC(C(=O)N)C1=CC=CC=C1 MSLAJOMOZIQQLT-UHFFFAOYSA-N 0.000 claims 2
- NKZHWEUPJPIVQG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(5-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNC(CC1)C)SC(C(=O)N)C1=CC=CC=C1 NKZHWEUPJPIVQG-UHFFFAOYSA-N 0.000 claims 2
- OTYYPWVAZKWPHH-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C2CN(C(C1)C2)C)SC(C(=O)N)C1=CC=CC=C1 OTYYPWVAZKWPHH-UHFFFAOYSA-N 0.000 claims 2
- DYRMDGWLQARAHJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(5-oxo-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNC(CC1)=O)SC(C(=O)N)C1=CC=CC=C1 DYRMDGWLQARAHJ-UHFFFAOYSA-N 0.000 claims 2
- LEXIGEPZZLZYMJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(6-fluoro-1,4-diazepan-1-yl)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCC(C1)F)SC(C(=O)N)C1=CC=CC=C1 LEXIGEPZZLZYMJ-UHFFFAOYSA-N 0.000 claims 2
- KYCSIHTYWHWBLQ-QRIPLOBPSA-N 2-[3,5-dicyano-4-ethyl-6-[(3R)-3-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CCC1)NC)SC(C(=O)N)C1=CC=CC=C1 KYCSIHTYWHWBLQ-QRIPLOBPSA-N 0.000 claims 2
- KYCSIHTYWHWBLQ-DJZRFWRSSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NC)SC(C(=O)N)C1=CC=CC=C1 KYCSIHTYWHWBLQ-DJZRFWRSSA-N 0.000 claims 2
- KUCBWFLVTKEBHS-LBOXEOMUSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-(oxetan-3-ylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NC1COC1)SC(C(=O)N)C1=CC=CC=C1 KUCBWFLVTKEBHS-LBOXEOMUSA-N 0.000 claims 2
- YPBGXKXOWKRFMU-PBVYKCSPSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-[(2-hydroxy-2-methylpropyl)amino]pyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)NCC(C)(C)O)SC(C(=O)N)C1=CC=CC=C1 YPBGXKXOWKRFMU-PBVYKCSPSA-N 0.000 claims 2
- FXMCLLNYHJNMHU-FAQQKDIKSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2,3-difluorophenyl)acetamide Chemical compound CCC1=C(C#N)C(SC(C(N)=O)C2=C(F)C(F)=CC=C2)=NC(N2CC[C@H](O)C2)=C1C#N FXMCLLNYHJNMHU-FAQQKDIKSA-N 0.000 claims 2
- LACBFVVSYQHECW-RSXQAXDFSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2,4-difluorophenyl)acetamide Chemical compound CCC1=C(C#N)C(SC(C(N)=O)C2=C(F)C=C(F)C=C2)=NC(N2CC[C@H](O)C2)=C1C#N LACBFVVSYQHECW-RSXQAXDFSA-N 0.000 claims 2
- AJRSRLUTGVVUQN-FAQQKDIKSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2,6-difluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=C(C=CC=C1F)F AJRSRLUTGVVUQN-FAQQKDIKSA-N 0.000 claims 2
- SGKXYWJWSIWWEY-RSXQAXDFSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(2-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=C(C=CC=C1)F SGKXYWJWSIWWEY-RSXQAXDFSA-N 0.000 claims 2
- OGVQOTBFEPJZRB-OOJLDXBWSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(3-dimethylphosphorylphenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC(=CC=C1)P(=O)(C)C OGVQOTBFEPJZRB-OOJLDXBWSA-N 0.000 claims 2
- HLAISKDDYRGCNF-PIVQAISJSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound CCC1=C(C#N)C(SC(C(N)=O)C2=CC=C(F)C=C2)=NC(N2CC[C@H](O)C2)=C1C#N HLAISKDDYRGCNF-PIVQAISJSA-N 0.000 claims 2
- ZLNMIQXSXVLFRG-WHUIICBVSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-pyridin-2-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=NC=CC=C1 ZLNMIQXSXVLFRG-WHUIICBVSA-N 0.000 claims 2
- IVLHXSIQOYWYEZ-CWQZNGJJSA-N 2-[3,5-dicyano-4-ethyl-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-pyridin-3-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C=1C=NC=CC=1 IVLHXSIQOYWYEZ-CWQZNGJJSA-N 0.000 claims 2
- BZTZVKGCRZLLBX-CWQZNGJJSA-N 2-[3,5-dicyano-4-ethyl-6-[(4S)-4-hydroxy-1,2-oxazolidin-2-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1OC[C@H](C1)O)SC(C(=O)N)C1=CC=CC=C1 BZTZVKGCRZLLBX-CWQZNGJJSA-N 0.000 claims 2
- BINSAYRDVGYJAZ-DCFJUCRTSA-N 2-[3,5-dicyano-4-ethyl-6-[(5S,6S)-6-hydroxy-1-methylsulfonyl-1,8-diazaspiro[4.5]decan-8-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H]([C@]2(CCCN2S(=O)(=O)C)CC1)O)SC(C(=O)N)C1=CC=CC=C1 BINSAYRDVGYJAZ-DCFJUCRTSA-N 0.000 claims 2
- XXLDDFUGJHQDRO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[1H-imidazol-2-ylmethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C(=NC=C1)CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C XXLDDFUGJHQDRO-UHFFFAOYSA-N 0.000 claims 2
- AEGNVXPUMDPJDQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[1H-imidazol-5-ylmethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C=NC=C1CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C AEGNVXPUMDPJDQ-UHFFFAOYSA-N 0.000 claims 2
- JSOIARXDGFXKJJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(2-fluoroethylamino)ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCNCCF)SC(C(=O)N)C1=CC=CC=C1 JSOIARXDGFXKJJ-UHFFFAOYSA-N 0.000 claims 2
- CFWYACPXXZHDAI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(2-methoxyethylamino)ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCNCCOC)SC(C(=O)N)C1=CC=CC=C1 CFWYACPXXZHDAI-UHFFFAOYSA-N 0.000 claims 2
- TVKFTXSUHZNTFK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(ethylamino)ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCNCC)SC(C(=O)N)C1=CC=CC=C1 TVKFTXSUHZNTFK-UHFFFAOYSA-N 0.000 claims 2
- GKIMTORUWNIQRW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(methylaminomethyl)morpholin-4-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CNC)SC(C(=O)N)C1=CC=CC=C1 GKIMTORUWNIQRW-UHFFFAOYSA-N 0.000 claims 2
- GWIYLVSLHAAZEW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-(pyrrolidin-1-ylmethyl)morpholin-4-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CN1CCCC1)SC(C(=O)N)C1=CC=CC=C1 GWIYLVSLHAAZEW-UHFFFAOYSA-N 0.000 claims 2
- LBMSTGPCJAOOAZ-ZZWBGTBQSA-N 2-[3,5-dicyano-4-ethyl-6-[2-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@H](CCC1)CO)SC(C(=O)N)C1=CC=CC=C1 LBMSTGPCJAOOAZ-ZZWBGTBQSA-N 0.000 claims 2
- LBMSTGPCJAOOAZ-HXBUSHRASA-N 2-[3,5-dicyano-4-ethyl-6-[2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@@H](CCC1)CO)SC(C(=O)N)C1=CC=CC=C1 LBMSTGPCJAOOAZ-HXBUSHRASA-N 0.000 claims 2
- ZIGAZNXZOLPFOS-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-[ethyl(methyl)amino]ethyl-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN(C)CC)SC(C(=O)N)C1=CC=CC=C1 ZIGAZNXZOLPFOS-UHFFFAOYSA-N 0.000 claims 2
- XOYGSTAJAGOUHB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-hydroxyethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCO)SC(C(=O)N)C1=CC=CC=C1 XOYGSTAJAGOUHB-UHFFFAOYSA-N 0.000 claims 2
- WUIIBRJZPQPKLB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[2-methoxyethyl(methyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCOC)SC(C(=O)N)C1=CC=CC=C1 WUIIBRJZPQPKLB-UHFFFAOYSA-N 0.000 claims 2
- HIQJFAUXGXYIDL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-(hydroxymethyl)azetidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C1)CO)SC(C(=O)N)C1=CC=CC=C1 HIQJFAUXGXYIDL-UHFFFAOYSA-N 0.000 claims 2
- TXXSJMRWNWLMIM-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-(methylamino)pyrrolidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CC1)NC)SC(C(=O)N)C1=CC=CC=C1 TXXSJMRWNWLMIM-UHFFFAOYSA-N 0.000 claims 2
- NJVYJNIZUSABLP-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-(methylaminomethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CCC1)CNC)SC(C(=O)N)C1=CC=CC=C1 NJVYJNIZUSABLP-UHFFFAOYSA-N 0.000 claims 2
- XHHMGEACDFDLES-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-[(2-hydroxyacetyl)amino]azetidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CC(C1)NC(CO)=O)C#N)CC)C#N)=O XHHMGEACDFDLES-UHFFFAOYSA-N 0.000 claims 2
- QPEAFCKDCCOTNE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[3-fluoro-4-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C(CC1)NC)F)SC(C(=O)N)C1=CC=CC=C1 QPEAFCKDCCOTNE-UHFFFAOYSA-N 0.000 claims 2
- KIZVFGMDTAUJBR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,2-oxazol-3-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=NOC=C1)SC(C(=O)N)C1=CC=CC=C1 KIZVFGMDTAUJBR-UHFFFAOYSA-N 0.000 claims 2
- RPQOZEOVRRPDEL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,2-oxazol-4-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC=1C=NOC=1)SC(C(=O)N)C1=CC=CC=C1 RPQOZEOVRRPDEL-UHFFFAOYSA-N 0.000 claims 2
- RKZBTUCLUHINBO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,2-thiazol-4-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC=1C=NSC=1)SC(C(=O)N)C1=CC=CC=C1 RKZBTUCLUHINBO-UHFFFAOYSA-N 0.000 claims 2
- IQOASBFTNDTNSC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,3-oxazol-2-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC=1OC=CN=1)SC(C(=O)N)C1=CC=CC=C1 IQOASBFTNDTNSC-UHFFFAOYSA-N 0.000 claims 2
- DSAZSJIGPVLSCJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,3-oxazol-5-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=CN=CO1)SC(C(=O)N)C1=CC=CC=C1 DSAZSJIGPVLSCJ-UHFFFAOYSA-N 0.000 claims 2
- PMIYBZXAPUTCHR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1,3-thiazol-5-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=CN=CS1)SC(C(=O)N)C1=CC=CC=C1 PMIYBZXAPUTCHR-UHFFFAOYSA-N 0.000 claims 2
- RNDSFIUHOPIRNK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1-hydroxy-2-methylpropan-2-yl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)C(CO)(C)C)SC(C(=O)N)C1=CC=C(C=C1)F RNDSFIUHOPIRNK-UHFFFAOYSA-N 0.000 claims 2
- XTVNNJYGSVPNGZ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1-hydroxy-2-methylpropan-2-yl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)C(CO)(C)C)SC(C(=O)N)C1=CC=CC=C1 XTVNNJYGSVPNGZ-UHFFFAOYSA-N 0.000 claims 2
- BTKQIZKHKDPADB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-imidazol-2-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C(=NC=C1)CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N BTKQIZKHKDPADB-UHFFFAOYSA-N 0.000 claims 2
- OMVYNAREKXDGRR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-imidazol-5-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C=NC=C1CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N OMVYNAREKXDGRR-UHFFFAOYSA-N 0.000 claims 2
- GFFDCWJMRYYKPH-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1N=CC(=C1)CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N GFFDCWJMRYYKPH-UHFFFAOYSA-N 0.000 claims 2
- CLTWRYNIRGEYRE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-pyrrol-2-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C(=CC=C1)CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N CLTWRYNIRGEYRE-UHFFFAOYSA-N 0.000 claims 2
- PEBIUNFFJUYUEC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(1H-pyrrol-3-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1C=C(C=C1)CN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PEBIUNFFJUYUEC-UHFFFAOYSA-N 0.000 claims 2
- XHCSPVVTYDYEFH-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxy-2-methylpropyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CC(C)(C)O)SC(C(=O)N)C1=CC=CC=C1 XHCSPVVTYDYEFH-UHFFFAOYSA-N 0.000 claims 2
- QXYIXZOLKPEBJL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethoxy)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)OCCO)SC(C(=O)N)C1=CC=CC=C1 QXYIXZOLKPEBJL-UHFFFAOYSA-N 0.000 claims 2
- IHXXDZHXEBKTKE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 IHXXDZHXEBKTKE-UHFFFAOYSA-N 0.000 claims 2
- HBKDLBCIDCHZSV-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)-3-oxopiperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(N(CC1)CCO)=O)SC(C(=O)N)C1=CC=CC=C1 HBKDLBCIDCHZSV-UHFFFAOYSA-N 0.000 claims 2
- DHHQTWDRYOCVNT-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CCO)SC(C(=O)N)C1=CC=CC=C1 DHHQTWDRYOCVNT-UHFFFAOYSA-N 0.000 claims 2
- BFMFJWREJHGPKE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxyethylamino)-4-(hydroxymethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)(CO)NCCO)SC(C(=O)N)C1=CC=CC=C1 BFMFJWREJHGPKE-UHFFFAOYSA-N 0.000 claims 2
- NTPKLKPQZNOIJT-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-hydroxypropyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CC(C)O)SC(C(=O)N)C1=CC=CC=C1 NTPKLKPQZNOIJT-UHFFFAOYSA-N 0.000 claims 2
- OQLDOBSEBOWDCU-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-methoxyethyl)-1,4-diazepan-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CCC1)CCOC)SC(C(=O)N)C1=CC=CC=C1 OQLDOBSEBOWDCU-UHFFFAOYSA-N 0.000 claims 2
- XICDBICWYVZRIF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-methoxyethylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCCOC)SC(C(=O)N)C1=CC=CC=C1 XICDBICWYVZRIF-UHFFFAOYSA-N 0.000 claims 2
- SEKRLNNIWWYPDC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-oxoimidazolidin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1C(NCC1)=O)SC(C(=O)N)C1=CC=CC=C1 SEKRLNNIWWYPDC-UHFFFAOYSA-N 0.000 claims 2
- XVIJFPOMYTUTOS-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(2-pyrrolidin-1-ylethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CCN1CCCC1)SC(C(=O)N)C1=CC=CC=C1 XVIJFPOMYTUTOS-UHFFFAOYSA-N 0.000 claims 2
- HMMVROADJJIGTL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CC(C1)OC)SC(C(=O)N)C1=CC=C(C=C1)F HMMVROADJJIGTL-UHFFFAOYSA-N 0.000 claims 2
- FHNBIFLOYRQNAW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(3-methoxyazetidin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CC(C1)OC)SC(C(=O)N)C1=CC=CC=C1 FHNBIFLOYRQNAW-UHFFFAOYSA-N 0.000 claims 2
- ZZGFAGXPUQJHON-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CCN(CC1)C)SC(C(=O)N)C1=CC=CC=C1 ZZGFAGXPUQJHON-UHFFFAOYSA-N 0.000 claims 2
- ZYLLCQFEFGXLIG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(furan-3-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=COC=C1)SC(C(=O)N)C1=CC=CC=C1 ZYLLCQFEFGXLIG-UHFFFAOYSA-N 0.000 claims 2
- KBKLXIFMIVJIII-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NC)SC(C(=O)N)C1=CC=C(C=C1)F KBKLXIFMIVJIII-UHFFFAOYSA-N 0.000 claims 2
- UFTKGXPMSNOOTN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(methylamino)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NC)SC(C(=O)N)C1=CC=CC=C1 UFTKGXPMSNOOTN-UHFFFAOYSA-N 0.000 claims 2
- GBWTUGZWJNAVLE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(oxetan-3-yloxy)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)OC1COC1)SC(C(=O)N)C1=CC=CC=C1 GBWTUGZWJNAVLE-UHFFFAOYSA-N 0.000 claims 2
- HOIWOTUORCYCGG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(pyridin-4-ylmethyl)piperazin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CC1=CC=NC=C1)SC(C(=O)N)C1=CC=CC=C1 HOIWOTUORCYCGG-UHFFFAOYSA-N 0.000 claims 2
- XXDQNQJEPNVGBO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-(pyrrolidin-1-ylmethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)CN1CCCC1)SC(C(=O)N)C1=CC=CC=C1 XXDQNQJEPNVGBO-UHFFFAOYSA-N 0.000 claims 2
- IVDBFJXQDPWQRW-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2-hydroxy-2-methylpropyl)-methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)CC(C)(C)O)SC(C(=O)N)C1=CC=CC=C1 IVDBFJXQDPWQRW-UHFFFAOYSA-N 0.000 claims 2
- SCMIHGKFSROBLR-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2-hydroxy-2-methylpropyl)amino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC(C)(C)O)SC(C(=O)N)C1=CC=C(C=C1)F SCMIHGKFSROBLR-UHFFFAOYSA-N 0.000 claims 2
- YMKSTCPMALFTRO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2-hydroxyacetyl)amino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)NC(CO)=O)C#N)CC)C#N)=O YMKSTCPMALFTRO-UHFFFAOYSA-N 0.000 claims 2
- AQAGUJBKESAHAB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2-methoxy-2-methylpropyl)-methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)CC(C)(C)OC)SC(C(=O)N)C1=CC=CC=C1 AQAGUJBKESAHAB-UHFFFAOYSA-N 0.000 claims 2
- MTIHTGQEJCRVHD-CGHJUBPDSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@H](CCC1)CO)SC(C(=O)N)C1=CC=CC=C1 MTIHTGQEJCRVHD-CGHJUBPDSA-N 0.000 claims 2
- UEARZJBSXHFNRJ-QFADGXAASA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2R)-2-methylpyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@@H](CCC1)C)SC(C(=O)N)C1=CC=CC=C1 UEARZJBSXHFNRJ-QFADGXAASA-N 0.000 claims 2
- MTIHTGQEJCRVHD-QHELBMECSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@@H](CCC1)CO)SC(C(=O)N)C1=CC=CC=C1 MTIHTGQEJCRVHD-QHELBMECSA-N 0.000 claims 2
- UEARZJBSXHFNRJ-VEXWJQHLSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(2S)-2-methylpyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@H](CCC1)C)SC(C(=O)N)C1=CC=CC=C1 UEARZJBSXHFNRJ-VEXWJQHLSA-N 0.000 claims 2
- IEGUDBMUKZBOIA-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(3-methyloxetan-3-yl)methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC1(COC1)C)SC(C(=O)N)C1=CC=CC=C1 IEGUDBMUKZBOIA-UHFFFAOYSA-N 0.000 claims 2
- UPIDRZFDVJKDAR-FKSKYRLFSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(3R)-3-fluoropyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1C[C@@H](CC1)F)SC(C(=O)N)C1=CC=CC=C1 UPIDRZFDVJKDAR-FKSKYRLFSA-N 0.000 claims 2
- UPIDRZFDVJKDAR-XNUZUHMRSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(3S)-3-fluoropyrrolidin-1-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1C[C@H](CC1)F)SC(C(=O)N)C1=CC=CC=C1 UPIDRZFDVJKDAR-XNUZUHMRSA-N 0.000 claims 2
- IQPDOUJLTIQQNF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(4-fluorophenyl)methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC1=CC=C(C=C1)F)SC(C(=O)N)C1=CC=CC=C1 IQPDOUJLTIQQNF-UHFFFAOYSA-N 0.000 claims 2
- NIWGXXSRIJYYQK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(6-methoxypyridin-2-yl)methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC1=NC(=CC=C1)OC)SC(C(=O)N)C1=CC=CC=C1 NIWGXXSRIJYYQK-UHFFFAOYSA-N 0.000 claims 2
- JZLXWXHKODYZML-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[(6-methoxypyridin-3-yl)methylamino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC=1C=NC(=CC=1)OC)SC(C(=O)N)C1=CC=CC=C1 JZLXWXHKODYZML-UHFFFAOYSA-N 0.000 claims 2
- RKMJIGDAMDXJMQ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[1-(2-hydroxyethyl)piperidin-4-yl]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)C1CCN(CC1)CCO)SC(C(=O)N)C1=CC=CC=C1 RKMJIGDAMDXJMQ-UHFFFAOYSA-N 0.000 claims 2
- SZJGIJPYCAHINT-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[2-hydroxyethyl(methyl)amino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)CCO)SC(C(=O)N)C1=CC=CC=C1 SZJGIJPYCAHINT-UHFFFAOYSA-N 0.000 claims 2
- MZUYDNIDARRTKI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-[ethyl(methyl)amino]piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)CC)SC(C(=O)N)C1=CC=CC=C1 MZUYDNIDARRTKI-UHFFFAOYSA-N 0.000 claims 2
- XZKAHJSGNPZLNY-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[4-hydroxy-4-(hydroxymethyl)piperidin-1-yl]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)(CO)O)SC(C(=O)N)C1=CC=CC=C1 XZKAHJSGNPZLNY-UHFFFAOYSA-N 0.000 claims 2
- YVMIQLHNHFIPJM-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(2-hydroxyethylamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCCO)C)C#N)CC)C#N)=O YVMIQLHNHFIPJM-UHFFFAOYSA-N 0.000 claims 2
- CSFVKQAXFPKGMN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1CC(C1)O)SC(C(=O)N)C1=CC=CC=C1 CSFVKQAXFPKGMN-UHFFFAOYSA-N 0.000 claims 2
- FHUNQIPUXZVGHZ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(3-hydroxypropylamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCCCO)C)C#N)CC)C#N)=O FHUNQIPUXZVGHZ-UHFFFAOYSA-N 0.000 claims 2
- PHJQREKPOYTERI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(4-hydroxypiperidin-1-yl)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1CCC(CC1)O)SC(C(=O)N)C1=CC=CC=C1 PHJQREKPOYTERI-UHFFFAOYSA-N 0.000 claims 2
- MMXJOQNWUOEIHO-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(hydroxyamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NO)C)C#N)CC)C#N)=O MMXJOQNWUOEIHO-UHFFFAOYSA-N 0.000 claims 2
- DOEGYPGFKNQPFF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-(methoxyamino)-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NOC)C)C#N)CC)C#N)=O DOEGYPGFKNQPFF-UHFFFAOYSA-N 0.000 claims 2
- ZIAOVEGAKJALAA-PLEWWHCXSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(2R)-2-(hydroxymethyl)morpholin-4-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H](OCC1)CO)SC(C(=O)N)C1=CC=CC=C1 ZIAOVEGAKJALAA-PLEWWHCXSA-N 0.000 claims 2
- ZIAOVEGAKJALAA-LBOXEOMUSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(2S)-2-(hydroxymethyl)morpholin-4-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H](OCC1)CO)SC(C(=O)N)C1=CC=CC=C1 ZIAOVEGAKJALAA-LBOXEOMUSA-N 0.000 claims 2
- ZAPHVOWJURLYDS-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3-hydroxy-2,2-dimethylpropyl)-methylamino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(C)CC(CO)(C)C)C)C#N)CC)C#N)=O ZAPHVOWJURLYDS-UHFFFAOYSA-N 0.000 claims 2
- SXIDJQRZNJGGHF-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3-hydroxy-2,2-dimethylpropyl)amino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCC(CO)(C)C)C)C#N)CC)C#N)=O SXIDJQRZNJGGHF-UHFFFAOYSA-N 0.000 claims 2
- DXRYEUXKCNACDD-XESZBRCGSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3R)-3-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H](CC1)CO)SC(C(=O)N)C1=CC=CC=C1 DXRYEUXKCNACDD-XESZBRCGSA-N 0.000 claims 2
- FWMQSCDFVUDXPV-UJONTBEJSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3R)-3-hydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 FWMQSCDFVUDXPV-UJONTBEJSA-N 0.000 claims 2
- SYVCBYSQKVUBDF-FLWMDHGKSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H]([C@H](C1)CO)O)SC(C(=O)N)C1=CC=CC=C1 SYVCBYSQKVUBDF-FLWMDHGKSA-N 0.000 claims 2
- SYVCBYSQKVUBDF-MZRGNRRKSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3R,4S)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H]([C@@H](C1)CO)O)SC(C(=O)N)C1=CC=CC=C1 SYVCBYSQKVUBDF-MZRGNRRKSA-N 0.000 claims 2
- DXRYEUXKCNACDD-CISYCMJJSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3S)-3-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H](CC1)CO)SC(C(=O)N)C1=CC=CC=C1 DXRYEUXKCNACDD-CISYCMJJSA-N 0.000 claims 2
- FWMQSCDFVUDXPV-BJQOMGFOSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3S)-3-hydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 FWMQSCDFVUDXPV-BJQOMGFOSA-N 0.000 claims 2
- SYVCBYSQKVUBDF-LMYOSFIVSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[(3S,4S)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H]([C@@H](C1)CO)O)SC(C(=O)N)C1=CC=CC=C1 SYVCBYSQKVUBDF-LMYOSFIVSA-N 0.000 claims 2
- REKRNEBMFQNOPB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[2-hydroxyethyl(methyl)amino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(C)CCO)C)C#N)CC)C#N)=O REKRNEBMFQNOPB-UHFFFAOYSA-N 0.000 claims 2
- RPHPDPXBKSZFBC-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[3-hydroxypropyl(methyl)amino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(C)CCCO)C)C#N)CC)C#N)=O RPHPDPXBKSZFBC-UHFFFAOYSA-N 0.000 claims 2
- KXCSCVBNPHMMHE-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[[1-(hydroxymethyl)cyclopropyl]methyl-methylamino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(C)CC1(CC1)CO)C)C#N)CC)C#N)=O KXCSCVBNPHMMHE-UHFFFAOYSA-N 0.000 claims 2
- WAVPTLOLGBOKPG-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[[1-(hydroxymethyl)cyclopropyl]methylamino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCC1(CC1)CO)C)C#N)CC)C#N)=O WAVPTLOLGBOKPG-UHFFFAOYSA-N 0.000 claims 2
- VLTAETQBPNTGJB-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[[2-[[3-(hydroxymethyl)oxetan-3-yl]amino]-2-oxoethyl]-methylamino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NC1(COC1)CO)C)C#N)CC)C#N)=O VLTAETQBPNTGJB-UHFFFAOYSA-N 0.000 claims 2
- PXDGHDPYXXCUOJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(1H-1,2,4-triazol-5-ylmethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N=1N=C(NC=1)CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C PXDGHDPYXXCUOJ-UHFFFAOYSA-N 0.000 claims 2
- XAGXVCSOGVMAKK-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(1H-pyrazol-5-ylmethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1N=C(C=C1)CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C XAGXVCSOGVMAKK-UHFFFAOYSA-N 0.000 claims 2
- QWCYDTNDPXJDQJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(2-morpholin-4-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1CCOCC1)C)SC(C(=O)N)C1=CC=CC=C1 QWCYDTNDPXJDQJ-UHFFFAOYSA-N 0.000 claims 2
- YOLKANZDCJBWCN-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(2-piperazin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1CCNCC1)C)SC(C(=O)N)C1=CC=CC=C1 YOLKANZDCJBWCN-UHFFFAOYSA-N 0.000 claims 2
- WSRKQFVILNOYDU-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(2-piperidin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1CCCCC1)C)SC(C(=O)N)C1=CC=CC=C1 WSRKQFVILNOYDU-UHFFFAOYSA-N 0.000 claims 2
- JRVWPOXQXJNLHI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl(2-pyrrolidin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1CCCC1)C)SC(C(=O)N)C1=CC=CC=C1 JRVWPOXQXJNLHI-UHFFFAOYSA-N 0.000 claims 2
- BXKMICZSTUMFTI-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-(1-methylpyrrolidin-3-yl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C1CN(CC1)C)C)SC(C(=O)N)C1=CC=CC=C1 BXKMICZSTUMFTI-UHFFFAOYSA-N 0.000 claims 2
- AZCDJBJGTWPUEH-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-(2-morpholin-4-yl-2-oxoethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC(=O)N1CCOCC1)C)SC(C(=O)N)C1=CC=CC=C1 AZCDJBJGTWPUEH-UHFFFAOYSA-N 0.000 claims 2
- QHGZKWOEXDKSNP-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-(2-oxo-2-piperazin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC(N1CCNCC1)=O)C)SC(C(=O)N)C1=CC=CC=C1 QHGZKWOEXDKSNP-UHFFFAOYSA-N 0.000 claims 2
- GOTMZVBKIJOKNM-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-(2-oxo-2-pyrrolidin-1-ylethyl)amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC(N1CCCC1)=O)C)SC(C(=O)N)C1=CC=CC=C1 GOTMZVBKIJOKNM-UHFFFAOYSA-N 0.000 claims 2
- YAGFDFMTNLEVAD-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-(1,2,4-triazol-4-yl)ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N=1N=CN(C=1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C YAGFDFMTNLEVAD-UHFFFAOYSA-N 0.000 claims 2
- FLMFAKLJVLHPCJ-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-(methylamino)ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCNC)C)SC(C(=O)N)C1=CC=CC=C1 FLMFAKLJVLHPCJ-UHFFFAOYSA-N 0.000 claims 2
- GYTNFNQZAZKEBM-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-[(1-methylcyclopropyl)amino]ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCNC1(CC1)C)C)SC(C(=O)N)C1=CC=CC=C1 GYTNFNQZAZKEBM-UHFFFAOYSA-N 0.000 claims 2
- AFYYBIJBKDLIFQ-PLEWWHCXSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-[(2R)-2-methylpyrrolidin-1-yl]ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1[C@@H](CCC1)C)C)SC(C(=O)N)C1=CC=CC=C1 AFYYBIJBKDLIFQ-PLEWWHCXSA-N 0.000 claims 2
- AFYYBIJBKDLIFQ-LBOXEOMUSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-[(2S)-2-methylpyrrolidin-1-yl]ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCN1[C@H](CCC1)C)C)SC(C(=O)N)C1=CC=CC=C1 AFYYBIJBKDLIFQ-LBOXEOMUSA-N 0.000 claims 2
- XMAWVXNSOLWLDD-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-[methyl-[2-oxo-2-[2-(1,2,4-triazol-4-yl)ethylamino]ethyl]amino]pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N=1N=CN(C=1)CCNC(CN(C)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)=O XMAWVXNSOLWLDD-UHFFFAOYSA-N 0.000 claims 2
- TYESDUSDOSXIOA-UHFFFAOYSA-N 2-[3,5-dicyano-6-(1,4-diazepan-1-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCNCCC1)SC(C(=O)N)C1=CC=CC=C1 TYESDUSDOSXIOA-UHFFFAOYSA-N 0.000 claims 2
- XWKHPFHSUYTASB-UHFFFAOYSA-N 2-[3,5-dicyano-6-(1,7-diazaspiro[3.5]nonan-1-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC11CCNCC1)SC(C(=O)N)C1=CC=CC=C1 XWKHPFHSUYTASB-UHFFFAOYSA-N 0.000 claims 2
- LEWPINXKUHMGEL-UHFFFAOYSA-N 2-[3,5-dicyano-6-(2,6-diazaspiro[3.4]octan-6-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2(CNC2)CC1)SC(C(=O)N)C1=CC=CC=C1 LEWPINXKUHMGEL-UHFFFAOYSA-N 0.000 claims 2
- JMLPWQOLWATUHA-UHFFFAOYSA-N 2-[3,5-dicyano-6-(2,7-diazaspiro[3.5]nonan-7-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CNC2)CC1)SC(C(=O)N)C1=CC=CC=C1 JMLPWQOLWATUHA-UHFFFAOYSA-N 0.000 claims 2
- BEBNLHNDQXVVCT-UHFFFAOYSA-N 2-[3,5-dicyano-6-(2,8-diazaspiro[4.5]decan-8-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCNC2)CC1)SC(C(=O)N)C1=CC=CC=C1 BEBNLHNDQXVVCT-UHFFFAOYSA-N 0.000 claims 2
- PXUHGLRILYSXLC-UHFFFAOYSA-N 2-[3,5-dicyano-6-(2,9-diazaspiro[5.5]undecan-9-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCCNC2)CC1)SC(C(=O)N)C1=CC=CC=C1 PXUHGLRILYSXLC-UHFFFAOYSA-N 0.000 claims 2
- XUKVOWURBPFJOR-UHFFFAOYSA-N 2-[3,5-dicyano-6-(3,4-dihydro-1H-2,7-naphthyridin-2-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2=CN=CC=C2CC1)SC(C(=O)N)C1=CC=CC=C1 XUKVOWURBPFJOR-UHFFFAOYSA-N 0.000 claims 2
- NDADFHCJBWQSAN-UHFFFAOYSA-N 2-[3,5-dicyano-6-(4,4-difluoropiperidin-1-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)(F)F)SC(C(=O)N)C1=CC=CC=C1 NDADFHCJBWQSAN-UHFFFAOYSA-N 0.000 claims 2
- MOMXNTDAKQMDGL-UHFFFAOYSA-N 2-[3,5-dicyano-6-(4-cyanopiperidin-1-yl)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)C#N)SC(C(=O)N)C1=CC=CC=C1 MOMXNTDAKQMDGL-UHFFFAOYSA-N 0.000 claims 2
- ZOKFQKIHTSQWMB-UHFFFAOYSA-N 2-[3,5-dicyano-6-(4-methyl-1,4-diazepan-1-yl)-4-methylsulfanylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1SC)C#N)N1CCN(CCC1)C)SC(C(=O)N)C1=CC=CC=C1 ZOKFQKIHTSQWMB-UHFFFAOYSA-N 0.000 claims 2
- VJZCIQKFGZRKOZ-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCC)C#N)N(C)C)SC(C(=O)N)C1=CC=CC=C1 VJZCIQKFGZRKOZ-UHFFFAOYSA-N 0.000 claims 2
- DGPYYDAKNCUFTM-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(3-dimethylphosphorylphenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC(=CC=C1)P(=O)(C)C DGPYYDAKNCUFTM-UHFFFAOYSA-N 0.000 claims 2
- XJPACZHPKYWNAI-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC=C(C=C1)F XJPACZHPKYWNAI-UHFFFAOYSA-N 0.000 claims 2
- JAOCSOYTIDHNNZ-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(5-fluoropyridin-2-yl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=NC=C(C=C1)F JAOCSOYTIDHNNZ-UHFFFAOYSA-N 0.000 claims 2
- RLKIRELOSIQUOZ-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(5-methoxypyridin-2-yl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=NC=C(C=C1)OC RLKIRELOSIQUOZ-UHFFFAOYSA-N 0.000 claims 2
- BKTPFLWAQPACLF-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-(5-methylpyridin-2-yl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=NC=C(C=C1)C BKTPFLWAQPACLF-UHFFFAOYSA-N 0.000 claims 2
- PBCCXXFCZHRVEH-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-[3-[2-(dimethylamino)ethoxy]phenyl]acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC(=CC=C1)OCCN(C)C PBCCXXFCZHRVEH-UHFFFAOYSA-N 0.000 claims 2
- XNLJPIURINSBAY-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-[4-(methylsulfamoyl)phenyl]acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC=C(C=C1)S(NC)(=O)=O XNLJPIURINSBAY-UHFFFAOYSA-N 0.000 claims 2
- KIEQQZZDWUNUQK-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC=CC=C1 KIEQQZZDWUNUQK-UHFFFAOYSA-N 0.000 claims 2
- PMUMTMWTHCXFJB-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-piperidin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1CCNCC1 PMUMTMWTHCXFJB-UHFFFAOYSA-N 0.000 claims 2
- CEFQBSLEFRRXOP-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-pyridin-4-ylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)C)SC(C(=O)N)C1=CC=NC=C1 CEFQBSLEFRRXOP-UHFFFAOYSA-N 0.000 claims 2
- PGEYCFMOSDKGRP-UHFFFAOYSA-N 2-[3,5-dicyano-6-(dimethylamino)-4-methoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OC)C#N)N(C)C)SC(C(=O)N)C1=CC=CC=C1 PGEYCFMOSDKGRP-UHFFFAOYSA-N 0.000 claims 2
- AXKAVBGAZHPOHC-HWYAHNCWSA-N 2-[3,5-dicyano-6-[(2R)-2-(diethylaminomethyl)morpholin-4-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](OCC1)CN(CC)CC)SC(C(=O)N)C1=CC=CC=C1 AXKAVBGAZHPOHC-HWYAHNCWSA-N 0.000 claims 2
- PDBFXYQPIAOBSW-HWYAHNCWSA-N 2-[3,5-dicyano-6-[(2R)-2-[(2,2-dimethylpropylamino)methyl]morpholin-4-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](OCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 PDBFXYQPIAOBSW-HWYAHNCWSA-N 0.000 claims 2
- PDBFXYQPIAOBSW-HSTJUUNISA-N 2-[3,5-dicyano-6-[(2S)-2-[(2,2-dimethylpropylamino)methyl]morpholin-4-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](OCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 PDBFXYQPIAOBSW-HSTJUUNISA-N 0.000 claims 2
- UXBDLRYUGBZZNB-QRIPLOBPSA-N 2-[3,5-dicyano-6-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 UXBDLRYUGBZZNB-QRIPLOBPSA-N 0.000 claims 2
- AODJRWVDEBWQQH-BJQOMGFOSA-N 2-[3,5-dicyano-6-[(3S)-3-(2,2-difluoroethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NCC(F)F)SC(C(=O)N)C1=CC=CC=C1 AODJRWVDEBWQQH-BJQOMGFOSA-N 0.000 claims 2
- GUZMORBPNRJGHC-HSTJUUNISA-N 2-[3,5-dicyano-6-[(3S)-3-(2,2-dimethylpropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 GUZMORBPNRJGHC-HSTJUUNISA-N 0.000 claims 2
- XRDSGFIUOVUAFR-HXBUSHRASA-N 2-[3,5-dicyano-6-[(3S)-3-(cyclopropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)NC1CC1)SC(C(=O)N)C1=CC=CC=C1 XRDSGFIUOVUAFR-HXBUSHRASA-N 0.000 claims 2
- TYRGVNLUHJKMQZ-PIVQAISJSA-N 2-[3,5-dicyano-6-[(3S)-3-(diaminomethylideneamino)oxypyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)ONC(=N)N)SC(C(=O)N)C1=CC=CC=C1 TYRGVNLUHJKMQZ-PIVQAISJSA-N 0.000 claims 2
- UXBDLRYUGBZZNB-DJZRFWRSSA-N 2-[3,5-dicyano-6-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 UXBDLRYUGBZZNB-DJZRFWRSSA-N 0.000 claims 2
- UMDFJCAWFVOWTN-XGLRFROISA-N 2-[3,5-dicyano-6-[(3S)-3-[(2,2-dimethylpropylamino)methyl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](CCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 UMDFJCAWFVOWTN-XGLRFROISA-N 0.000 claims 2
- JVFVJIMPWTUARY-CWQZNGJJSA-N 2-[3,5-dicyano-6-[(3S)-3-hydroxypyrrolidin-1-yl]-4-methoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OC)C#N)N1C[C@H](CC1)O)SC(C(=O)N)C1=CC=CC=C1 JVFVJIMPWTUARY-CWQZNGJJSA-N 0.000 claims 2
- YNRHPBVVQIDNPF-JWTNVVGKSA-N 2-[3,5-dicyano-6-[(3S,4R)-3,4-dihydroxypyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H]([C@@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 YNRHPBVVQIDNPF-JWTNVVGKSA-N 0.000 claims 2
- PJLCPZDEFOJRNH-DBIVSCPCSA-N 2-[3,5-dicyano-6-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@@H](N[C@@H](C1)C)C)SC(C(=O)N)C1=CC=CC=C1 PJLCPZDEFOJRNH-DBIVSCPCSA-N 0.000 claims 2
- XMZRJKUIERXLEA-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(2,2-dimethylpropylamino)ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CCNCC(C)(C)C)C)SC(C(=O)N)C1=CC=CC=C1 XMZRJKUIERXLEA-UHFFFAOYSA-N 0.000 claims 2
- FLQWEYKWBPGAQZ-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(cyclopropylmethyl)-2,9-diazaspiro[5.5]undecan-9-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC2(CCCN(C2)CC2CC2)CC1)SC(C(=O)N)C1=CC=CC=C1 FLQWEYKWBPGAQZ-UHFFFAOYSA-N 0.000 claims 2
- XXJFYRYKHCNOQK-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(diaminomethylideneamino)oxyethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCONC(=N)N)SC(C(=O)N)C1=CC=CC=C1 XXJFYRYKHCNOQK-UHFFFAOYSA-N 0.000 claims 2
- BIZYAOCWRROOTD-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(diethylamino)ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN(CC)CC)SC(C(=O)N)C1=CC=CC=C1 BIZYAOCWRROOTD-UHFFFAOYSA-N 0.000 claims 2
- AXKAVBGAZHPOHC-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(diethylaminomethyl)morpholin-4-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CN(CC)CC)SC(C(=O)N)C1=CC=CC=C1 AXKAVBGAZHPOHC-UHFFFAOYSA-N 0.000 claims 2
- QBTLPLHSROYOIB-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(dimethylamino)ethoxy]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)OCCN(C)C)SC(C(=O)N)C1=CC=CC=C1 QBTLPLHSROYOIB-UHFFFAOYSA-N 0.000 claims 2
- CMFOAXMRKJAQAS-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(dimethylamino)ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN(C)C)SC(C(=O)N)C1=CC=CC=C1 CMFOAXMRKJAQAS-UHFFFAOYSA-N 0.000 claims 2
- XDSCOQKNRNKTDB-UHFFFAOYSA-N 2-[3,5-dicyano-6-[2-(dimethylamino)ethylsulfanyl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)SCCN(C)C)SC(C(=O)N)C1=CC=CC=C1 XDSCOQKNRNKTDB-UHFFFAOYSA-N 0.000 claims 2
- GJEASOAIHWLCJZ-JGUPTHKFSA-N 2-[3,5-dicyano-6-[2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@@H](CC[C@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 GJEASOAIHWLCJZ-JGUPTHKFSA-N 0.000 claims 2
- GJEASOAIHWLCJZ-NHJWOMDBSA-N 2-[3,5-dicyano-6-[2-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@H](CC[C@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 GJEASOAIHWLCJZ-NHJWOMDBSA-N 0.000 claims 2
- GJEASOAIHWLCJZ-JOHXPNBHSA-N 2-[3,5-dicyano-6-[2-[(2S,5S)-2,5-dimethylpyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1[C@H](CC[C@@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 GJEASOAIHWLCJZ-JOHXPNBHSA-N 0.000 claims 2
- NITLTHGIWLRPFL-HWYAHNCWSA-N 2-[3,5-dicyano-6-[2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1C[C@@H](CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 NITLTHGIWLRPFL-HWYAHNCWSA-N 0.000 claims 2
- NITLTHGIWLRPFL-HSTJUUNISA-N 2-[3,5-dicyano-6-[2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]ethyl-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CCN1C[C@H](CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 NITLTHGIWLRPFL-HSTJUUNISA-N 0.000 claims 2
- ZGBWULPYTNVDDE-UHFFFAOYSA-N 2-[3,5-dicyano-6-[3-(diaminomethylideneamino)oxyazetidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C1)ONC(=N)N)SC(C(=O)N)C1=CC=CC=C1 ZGBWULPYTNVDDE-UHFFFAOYSA-N 0.000 claims 2
- OGHLVJPRXFDONV-UHFFFAOYSA-N 2-[3,5-dicyano-6-[3-[(dimethylamino)methyl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CCC1)CN(C)C)SC(C(=O)N)C1=CC=CC=C1 OGHLVJPRXFDONV-UHFFFAOYSA-N 0.000 claims 2
- CPKKLVQNKMXDBL-UHFFFAOYSA-N 2-[3,5-dicyano-6-[3-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(CC1)CN(C)C)SC(C(=O)N)C1=CC=CC=C1 CPKKLVQNKMXDBL-UHFFFAOYSA-N 0.000 claims 2
- MQDOWKIITDXHFY-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,2-difluoroethylamino)-4-methylpiperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)(C)NCC(F)F)SC(C(=O)N)C1=CC=CC=C1 MQDOWKIITDXHFY-UHFFFAOYSA-N 0.000 claims 2
- NRXLLIYFPGEQKW-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,2-difluoroethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC(F)F)SC(C(=O)N)C1=CC=CC=C1 NRXLLIYFPGEQKW-UHFFFAOYSA-N 0.000 claims 2
- KYWHKTGBQIOFPC-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,2-dimethylpropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC(C)(C)C)SC(C(=O)N)C1=CC=C(C=C1)F KYWHKTGBQIOFPC-UHFFFAOYSA-N 0.000 claims 2
- NUOFNLUIHZRQHJ-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,2-dimethylpropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NCC(C)(C)C)SC(C(=O)N)C1=CC=CC=C1 NUOFNLUIHZRQHJ-UHFFFAOYSA-N 0.000 claims 2
- JCXGKQLJABWGKP-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2,5-dioxoimidazolidin-1-yl)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1C(NCC1=O)=O)SC(C(=O)N)C1=CC=CC=C1 JCXGKQLJABWGKP-UHFFFAOYSA-N 0.000 claims 2
- FZYBTOYDEPQYRI-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]-4-methoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 FZYBTOYDEPQYRI-UHFFFAOYSA-N 0.000 claims 2
- WBNRGSXBRABHNI-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(2-hydroxyethyl)-1,4-diazepan-1-yl]-4-propoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1OCCC)C#N)N1CCN(CCC1)CCO)SC(C(=O)N)C1=CC=CC=C1 WBNRGSXBRABHNI-UHFFFAOYSA-N 0.000 claims 2
- KKHSDHHCWMBFOK-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(3,3-difluoropyrrolidin-1-yl)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1CC(CC1)(F)F)SC(C(=O)N)C1=CC=CC=C1 KKHSDHHCWMBFOK-UHFFFAOYSA-N 0.000 claims 2
- OHYCOVOLCLJBIQ-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(cyclobutylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NC1CCC1)SC(C(=O)N)C1=CC=CC=C1 OHYCOVOLCLJBIQ-UHFFFAOYSA-N 0.000 claims 2
- BZCKIEYSRQOOEW-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(cyclopropylamino)-3-fluoropiperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(C(CC1)NC1CC1)F)SC(C(=O)N)C1=CC=CC=C1 BZCKIEYSRQOOEW-UHFFFAOYSA-N 0.000 claims 2
- WLGBTBSZMJKZFA-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(cyclopropylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)NC1CC1)SC(C(=O)N)C1=CC=CC=C1 WLGBTBSZMJKZFA-UHFFFAOYSA-N 0.000 claims 2
- BUFHWVIJQMGNTB-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(diaminomethylideneamino)oxypiperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)ONC(=N)N)SC(C(=O)N)C1=CC=CC=C1 BUFHWVIJQMGNTB-UHFFFAOYSA-N 0.000 claims 2
- DICLIVFTTAAJBE-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(2,4-difluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=C(C=C(C=C1)F)F DICLIVFTTAAJBE-UHFFFAOYSA-N 0.000 claims 2
- COCVXPUQYSCVKV-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(3,4-difluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=CC(=C(C=C1)F)F COCVXPUQYSCVKV-UHFFFAOYSA-N 0.000 claims 2
- MELQQCMEXPGRLW-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-(dimethylamino)piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C)SC(C(=O)N)C1=CC=CC=C1 MELQQCMEXPGRLW-UHFFFAOYSA-N 0.000 claims 2
- JMHYFCLKDJIHGI-CKPMZPGQSA-N 2-[3,5-dicyano-6-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@@H](CC[C@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 JMHYFCLKDJIHGI-CKPMZPGQSA-N 0.000 claims 2
- JMHYFCLKDJIHGI-OOEJVQDLSA-N 2-[3,5-dicyano-6-[4-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@@H](CC[C@@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 JMHYFCLKDJIHGI-OOEJVQDLSA-N 0.000 claims 2
- JMHYFCLKDJIHGI-NHDFCTKWSA-N 2-[3,5-dicyano-6-[4-[(2S,5S)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N1[C@H](CC[C@@H]1C)C)SC(C(=O)N)C1=CC=CC=C1 JMHYFCLKDJIHGI-NHDFCTKWSA-N 0.000 claims 2
- SGDORTBLSHVRCN-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-[3-(dimethylamino)propyl]piperazin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)CCCN(C)C)SC(C(=O)N)C1=CC=CC=C1 SGDORTBLSHVRCN-UHFFFAOYSA-N 0.000 claims 2
- WAUGZLFVUIBDBC-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-[cyclobutyl(methyl)amino]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C1CCC1)SC(C(=O)N)C1=CC=C(C=C1)F WAUGZLFVUIBDBC-UHFFFAOYSA-N 0.000 claims 2
- WYIMAUGPLBALGL-UHFFFAOYSA-N 2-[3,5-dicyano-6-[4-[cyclobutyl(methyl)amino]piperidin-1-yl]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(C)C1CCC1)SC(C(=O)N)C1=CC=CC=C1 WYIMAUGPLBALGL-UHFFFAOYSA-N 0.000 claims 2
- IRHOOYHPPHGTRC-UHFFFAOYSA-N 2-[3,5-dicyano-6-[[2-(1,3-dihydroxypropan-2-ylamino)-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NC(CO)CO)C)C#N)CC)C#N)=O IRHOOYHPPHGTRC-UHFFFAOYSA-N 0.000 claims 2
- JOXMAWTUMNYVAU-AQFHOAJTSA-N 2-[3,5-dicyano-6-[[2-[(3R,4R)-3,4-dihydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H]([C@@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 JOXMAWTUMNYVAU-AQFHOAJTSA-N 0.000 claims 2
- JOXMAWTUMNYVAU-PMSBKCLSSA-N 2-[3,5-dicyano-6-[[2-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@H]([C@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 JOXMAWTUMNYVAU-PMSBKCLSSA-N 0.000 claims 2
- JOXMAWTUMNYVAU-CHEUHSMRSA-N 2-[3,5-dicyano-6-[[2-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H]([C@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 JOXMAWTUMNYVAU-CHEUHSMRSA-N 0.000 claims 2
- TUGBHEYYCADQIE-AQKKSAQBSA-N 2-[3,5-dicyano-6-[[2-[(3S,5R)-3,5-dihydroxypiperidin-1-yl]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(C)CC(=O)N1C[C@@H](C[C@@H](C1)O)O)SC(C(=O)N)C1=CC=CC=C1 TUGBHEYYCADQIE-AQKKSAQBSA-N 0.000 claims 2
- RHNQQNKFFAMZHT-IWPPFLRJSA-N 2-[3,5-dicyano-6-[[2-[[(2R)-2,3-dihydroxypropyl]amino]-2-oxoethyl]-methylamino]-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NC[C@H](CO)O)C)C#N)CC)C#N)=O RHNQQNKFFAMZHT-IWPPFLRJSA-N 0.000 claims 2
- IMKNMPXUIJTVKF-UHFFFAOYSA-N 2-[4-(2-amino-2-oxoethyl)phenyl]-2-[3,5-dicyano-4-ethyl-6-(4-methyl-1,4-diazepan-1-yl)pyridin-2-yl]sulfanylacetamide Chemical compound NC(CC1=CC=C(C=C1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N1CCN(CCC1)C)=O IMKNMPXUIJTVKF-UHFFFAOYSA-N 0.000 claims 2
- MBQJFQOCMNTMNQ-UHFFFAOYSA-N 2-[4-(2-amino-2-oxoethyl)phenyl]-2-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanylacetamide Chemical compound NC(CC1=CC=C(C=C1)C(C(=O)N)SC1=NC(=C(C(=C1C#N)CC)C#N)N(C)C)=O MBQJFQOCMNTMNQ-UHFFFAOYSA-N 0.000 claims 2
- LZZBRZDORPAYHM-UHFFFAOYSA-N 2-[6-(1,3,4,5,7,8,9,9a-octahydropyrrolo[1,2-a][1,4]diazepin-2-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2N(CCC1)CCC2)SC(C(=O)N)C1=CC=CC=C1 LZZBRZDORPAYHM-UHFFFAOYSA-N 0.000 claims 2
- PPXIQBJVGVIWDI-UHFFFAOYSA-N 2-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)SC(C(=O)N)C1=CC=CC=C1)SC(C(=O)N)C1=CC=CC=C1 PPXIQBJVGVIWDI-UHFFFAOYSA-N 0.000 claims 2
- IKEVWYBPAUJEDN-UHFFFAOYSA-N 2-[6-(2-amino-2-oxoethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CSC1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)=O IKEVWYBPAUJEDN-UHFFFAOYSA-N 0.000 claims 2
- AUSILSIUFIKOSS-UHFFFAOYSA-N 2-[6-(3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC2OCCNC2C1)SC(C(=O)N)C1=CC=CC=C1 AUSILSIUFIKOSS-UHFFFAOYSA-N 0.000 claims 2
- ZGFSVDFCYOMEJY-UHFFFAOYSA-N 2-[6-(3-aminopiperidin-1-yl)-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CN(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N ZGFSVDFCYOMEJY-UHFFFAOYSA-N 0.000 claims 2
- WOFWYIKKGDFRKO-UHFFFAOYSA-N 2-[6-(4-acetylpiperazin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(C)(=O)N1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N WOFWYIKKGDFRKO-UHFFFAOYSA-N 0.000 claims 2
- LWCTZINLTSJCET-UHFFFAOYSA-N 2-[6-(4-amino-3,3-difluoropiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1C(CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)(F)F LWCTZINLTSJCET-UHFFFAOYSA-N 0.000 claims 2
- BEWQRCQQIKNSEB-UHFFFAOYSA-N 2-[6-(4-amino-4-methylpiperidin-1-yl)-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)C BEWQRCQQIKNSEB-UHFFFAOYSA-N 0.000 claims 2
- ALNFMEKLSGMBDG-UHFFFAOYSA-N 2-[6-(4-aminopiperazin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N ALNFMEKLSGMBDG-UHFFFAOYSA-N 0.000 claims 2
- UTKLFRLMLLGCFI-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N UTKLFRLMLLGCFI-UHFFFAOYSA-N 0.000 claims 2
- MUZQFFCMSJIQRT-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-(3-fluoropyridin-2-yl)acetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=NC=CC=C1F)C#N)CC)C#N MUZQFFCMSJIQRT-UHFFFAOYSA-N 0.000 claims 2
- CZNRJQMBRCCVPE-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-(4-fluorophenyl)acetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=C(C=C1)F)C#N)CC)C#N CZNRJQMBRCCVPE-UHFFFAOYSA-N 0.000 claims 2
- HCPBFQRBYJPHKZ-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-[4-(trifluoromethyl)phenyl]acetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=C(C=C1)C(F)(F)F)C#N)CC)C#N HCPBFQRBYJPHKZ-UHFFFAOYSA-N 0.000 claims 2
- KNKHRZYILDZLRE-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KNKHRZYILDZLRE-UHFFFAOYSA-N 0.000 claims 2
- OYAWXAXYBNYPBS-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-methoxypyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)OC)C#N OYAWXAXYBNYPBS-UHFFFAOYSA-N 0.000 claims 2
- UOBFRXJLZIFHJN-UHFFFAOYSA-N 2-[6-(4-aminopiperidin-1-yl)-3-cyano-4-ethyl-5-methylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C UOBFRXJLZIFHJN-UHFFFAOYSA-N 0.000 claims 2
- QPYOXRCZBIGMHI-UHFFFAOYSA-N 2-[6-(4-benzoylpiperazin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(C1=CC=CC=C1)(=O)N1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N QPYOXRCZBIGMHI-UHFFFAOYSA-N 0.000 claims 2
- SRZPYPCNFUTKLJ-UHFFFAOYSA-N 2-[6-(azetidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N SRZPYPCNFUTKLJ-UHFFFAOYSA-N 0.000 claims 2
- WEGOHWICAIDWSC-UHFFFAOYSA-N 2-[6-[(2-amino-2-oxoethyl)-methylamino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)C)=O WEGOHWICAIDWSC-UHFFFAOYSA-N 0.000 claims 2
- PMWNNSZNZVXNKL-NYRJJRHWSA-N 2-[6-[(2R)-2-(aminomethyl)morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@H]1OCCN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PMWNNSZNZVXNKL-NYRJJRHWSA-N 0.000 claims 2
- LNKYKKANMBILNL-UJONTBEJSA-N 2-[6-[(2R)-2-[[(2-aminoacetyl)amino]methyl]morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC(=O)NC[C@@H]1CN(CCO1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1 LNKYKKANMBILNL-UJONTBEJSA-N 0.000 claims 2
- PMWNNSZNZVXNKL-FUKCDUGKSA-N 2-[6-[(2S)-2-(aminomethyl)morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@@H]1OCCN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PMWNNSZNZVXNKL-FUKCDUGKSA-N 0.000 claims 2
- LNKYKKANMBILNL-BJQOMGFOSA-N 2-[6-[(2S)-2-[[(2-aminoacetyl)amino]methyl]morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC(=O)NC[C@H]1CN(CCO1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1 LNKYKKANMBILNL-BJQOMGFOSA-N 0.000 claims 2
- RNQDUYUPMICSPU-UHFFFAOYSA-N 2-[6-[(3-aminocyclobutyl)-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1CC(C1)N(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C RNQDUYUPMICSPU-UHFFFAOYSA-N 0.000 claims 2
- SLFVOEJIFPFHPQ-LMNIDFBRSA-N 2-[6-[(3R)-3-(aminomethyl)-3-fluoropyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@]1(CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F SLFVOEJIFPFHPQ-LMNIDFBRSA-N 0.000 claims 2
- FFCIAYQYQHQCAI-NYRJJRHWSA-N 2-[6-[(3R)-3-aminopiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1CN(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N FFCIAYQYQHQCAI-NYRJJRHWSA-N 0.000 claims 2
- KBEGRXPEEBEXGI-IKJXHCRLSA-N 2-[6-[(3R)-3-aminopyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KBEGRXPEEBEXGI-IKJXHCRLSA-N 0.000 claims 2
- XQNVHJPYTYGCQE-OOJLDXBWSA-N 2-[6-[(3S)-3-(aminomethyl)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC[C@H]1CN(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N XQNVHJPYTYGCQE-OOJLDXBWSA-N 0.000 claims 2
- GYGKBXDKKKPZHQ-CISYCMJJSA-N 2-[6-[(3S)-3-[[(2-aminoacetyl)amino]methyl]piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC(=O)NC[C@H]1CN(CCC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1 GYGKBXDKKKPZHQ-CISYCMJJSA-N 0.000 claims 2
- FFCIAYQYQHQCAI-FUKCDUGKSA-N 2-[6-[(3S)-3-aminopiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1CN(CCC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N FFCIAYQYQHQCAI-FUKCDUGKSA-N 0.000 claims 2
- XSBOMFPXGIVJLB-FUKCDUGKSA-N 2-[6-[(3S)-3-aminopyrrolidin-1-yl]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N XSBOMFPXGIVJLB-FUKCDUGKSA-N 0.000 claims 2
- KBEGRXPEEBEXGI-PIVQAISJSA-N 2-[6-[(3S)-3-aminopyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KBEGRXPEEBEXGI-PIVQAISJSA-N 0.000 claims 2
- YWBVSTLJPZTNFH-UHFFFAOYSA-N 2-[6-[2-(2-aminoethoxy)ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCOCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C YWBVSTLJPZTNFH-UHFFFAOYSA-N 0.000 claims 2
- PMWNNSZNZVXNKL-UHFFFAOYSA-N 2-[6-[2-(aminomethyl)morpholin-4-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1OCCN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N PMWNNSZNZVXNKL-UHFFFAOYSA-N 0.000 claims 2
- JVYSQUPZSLVXHG-UHFFFAOYSA-N 2-[6-[2-(azepan-1-yl)ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(CCCCCC1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C JVYSQUPZSLVXHG-UHFFFAOYSA-N 0.000 claims 2
- XCJYJCQYRHMCIO-OQHSHRKDSA-N 2-[6-[2-[(3R)-3-aminopyrrolidin-1-yl]ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@H]1CN(CC1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C XCJYJCQYRHMCIO-OQHSHRKDSA-N 0.000 claims 2
- XCJYJCQYRHMCIO-PBVYKCSPSA-N 2-[6-[2-[(3S)-3-aminopyrrolidin-1-yl]ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N[C@@H]1CN(CC1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C XCJYJCQYRHMCIO-PBVYKCSPSA-N 0.000 claims 2
- QDSUGZANEFECHV-UHFFFAOYSA-N 2-[6-[2-[4-(aminomethyl)-4-hydroxypiperidin-1-yl]ethyl-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1(CCN(CC1)CCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C)O QDSUGZANEFECHV-UHFFFAOYSA-N 0.000 claims 2
- KQXPWVJENBGGLC-UHFFFAOYSA-N 2-[6-[2-aminoethyl(methyl)amino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)C KQXPWVJENBGGLC-UHFFFAOYSA-N 0.000 claims 2
- FGEUXSPNUVMYFN-UHFFFAOYSA-N 2-[6-[2-aminoethyl(methyl)amino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C FGEUXSPNUVMYFN-UHFFFAOYSA-N 0.000 claims 2
- GEDMGGLPWSSKKL-UHFFFAOYSA-N 2-[6-[3-(2-amino-2-oxoethyl)azetidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CC1CN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)=O GEDMGGLPWSSKKL-UHFFFAOYSA-N 0.000 claims 2
- BNSFJHRMFNFDAG-UHFFFAOYSA-N 2-[6-[3-(aminomethyl)-3-fluoroazetidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1(CN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)F BNSFJHRMFNFDAG-UHFFFAOYSA-N 0.000 claims 2
- OQGJRMRSVCAYGC-UHFFFAOYSA-N 2-[6-[3-(aminomethyl)azetidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1CN(C1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N OQGJRMRSVCAYGC-UHFFFAOYSA-N 0.000 claims 2
- NZDNIYAPZBEWSL-UHFFFAOYSA-N 2-[6-[3-(aminomethyl)pyrrolidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1CN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N NZDNIYAPZBEWSL-UHFFFAOYSA-N 0.000 claims 2
- ZZEYJFMVGDINRK-UHFFFAOYSA-N 2-[6-[3-aminopropyl(methyl)amino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)C ZZEYJFMVGDINRK-UHFFFAOYSA-N 0.000 claims 2
- VWIPKZUTTPRYHJ-UHFFFAOYSA-N 2-[6-[3-aminopropyl(methyl)amino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCCN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C VWIPKZUTTPRYHJ-UHFFFAOYSA-N 0.000 claims 2
- RJOBZQUOAKRYGL-UHFFFAOYSA-N 2-[6-[4-(2-aminoethoxy)piperidin-1-yl]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCOC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N RJOBZQUOAKRYGL-UHFFFAOYSA-N 0.000 claims 2
- BLZTZJSUGNBLSO-UHFFFAOYSA-N 2-[6-[4-(2-aminoethoxy)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCOC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N BLZTZJSUGNBLSO-UHFFFAOYSA-N 0.000 claims 2
- MAFFWBYHTVLIIC-UHFFFAOYSA-N 2-[6-[4-(2-aminoethyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N MAFFWBYHTVLIIC-UHFFFAOYSA-N 0.000 claims 2
- ITNCPVQXCAIRIB-UHFFFAOYSA-N 2-[6-[4-(2-aminoethylamino)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCNC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N ITNCPVQXCAIRIB-UHFFFAOYSA-N 0.000 claims 2
- WXFQMTXWVFGFAT-UHFFFAOYSA-N 2-[6-[4-(3-amino-2-oxopyrrolidin-1-yl)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1C(N(CC1)C1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)=O WXFQMTXWVFGFAT-UHFFFAOYSA-N 0.000 claims 2
- UFWLOSHEGGYLCG-UHFFFAOYSA-N 2-[6-[4-(3-aminooxetane-3-carbonyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(COC1)C(=O)N1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N UFWLOSHEGGYLCG-UHFFFAOYSA-N 0.000 claims 2
- VSKHLYUJBSIEJD-UHFFFAOYSA-N 2-[6-[4-(3-aminopropyl)piperazin-1-yl]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCCN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N VSKHLYUJBSIEJD-UHFFFAOYSA-N 0.000 claims 2
- VPSZPHFSSKMVRD-UHFFFAOYSA-N 2-[6-[4-(3-aminopropyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCCCN1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N VPSZPHFSSKMVRD-UHFFFAOYSA-N 0.000 claims 2
- QNPCTZHGKDIXRX-UHFFFAOYSA-N 2-[6-[4-(4-aminooxane-4-carbonyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(CCOCC1)C(=O)N1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N QNPCTZHGKDIXRX-UHFFFAOYSA-N 0.000 claims 2
- VZGOPXHEQIDXJK-UHFFFAOYSA-N 2-[6-[4-(4-bromobenzoyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound BrC1=CC=C(C(=O)N2CCN(CC2)C2=C(C(=C(C(=N2)SC(C(=O)N)C2=CC=CC=C2)C#N)CC)C#N)C=C1 VZGOPXHEQIDXJK-UHFFFAOYSA-N 0.000 claims 2
- OUYJFIBXLUPLFP-UHFFFAOYSA-N 2-[6-[4-(aminomethyl)-4-fluoropiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide hydrochloride Chemical compound Cl.CCc1c(C#N)c(SC(C(N)=O)c2ccccc2)nc(N2CCC(F)(CN)CC2)c1C#N OUYJFIBXLUPLFP-UHFFFAOYSA-N 0.000 claims 2
- PHKYZYTYHPGLTD-UHFFFAOYSA-N 2-[6-[4-(aminomethyl)-4-hydroxypiperidin-1-yl]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N)O PHKYZYTYHPGLTD-UHFFFAOYSA-N 0.000 claims 2
- ORQSOUJPOUNSOO-UHFFFAOYSA-N 2-[6-[4-(aminomethyl)-4-hydroxypiperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NCC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)O ORQSOUJPOUNSOO-UHFFFAOYSA-N 0.000 claims 2
- GRSYUHUEJLXKJY-UHFFFAOYSA-N 2-[6-[4-(benzenesulfonyl)piperazin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCN(CC1)S(=O)(=O)C1=CC=CC=C1)SC(C(=O)N)C1=CC=CC=C1 GRSYUHUEJLXKJY-UHFFFAOYSA-N 0.000 claims 2
- KMSVUGZZCMCBRE-UHFFFAOYSA-N 2-[6-[4-(benzylamino)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(C1=CC=CC=C1)NC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N KMSVUGZZCMCBRE-UHFFFAOYSA-N 0.000 claims 2
- TXNOJGRGASUJRM-UHFFFAOYSA-N 2-[6-[4-[(2-amino-2-oxoethyl)amino]piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(CNC1CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)=O TXNOJGRGASUJRM-UHFFFAOYSA-N 0.000 claims 2
- VHBPEOQXYPCLBX-UHFFFAOYSA-N 2-[6-[4-amino-4-(hydroxymethyl)piperidin-1-yl]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC1(CCN(CC1)C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)CO VHBPEOQXYPCLBX-UHFFFAOYSA-N 0.000 claims 2
- NXJFBTGSTBPGSE-UHFFFAOYSA-N 2-[6-[8-azabicyclo[3.2.1]octan-3-yl(methyl)amino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C12CC(CC(CC1)N2)N(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C NXJFBTGSTBPGSE-UHFFFAOYSA-N 0.000 claims 2
- YDZPPICNOQHQEC-UHFFFAOYSA-N 2-[6-[[2-(2-aminoethylamino)-2-oxoethyl]-methylamino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide hydrochloride Chemical compound Cl.CN(CC(=O)NCCN)c1nc(SC(C(N)=O)c2ccccc2)c(C#N)c(C2CC2)c1C#N YDZPPICNOQHQEC-UHFFFAOYSA-N 0.000 claims 2
- PDQXUGIJXRCATP-UHFFFAOYSA-N 2-[6-[[2-(2-aminoethylamino)-2-oxoethyl]-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)NCCN)C)C#N)CC)C#N)=O PDQXUGIJXRCATP-UHFFFAOYSA-N 0.000 claims 2
- NXUFAFHTUATDHM-UHFFFAOYSA-N 2-[6-[[2-(azetidin-1-yl)-2-oxoethyl]-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound N1(CCC1)C(CN(C1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)CC)C#N)C)=O NXUFAFHTUATDHM-UHFFFAOYSA-N 0.000 claims 2
- LDXIFMPGKWMLRA-UHFFFAOYSA-N 2-[6-[[2-[bis(2-hydroxyethyl)amino]-2-oxoethyl]-methylamino]-3,5-dicyano-4-cyclopropylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(CCO)CCO)C)C#N)C1CC1)C#N)=O LDXIFMPGKWMLRA-UHFFFAOYSA-N 0.000 claims 2
- PWKQIYKPPHHUCG-UHFFFAOYSA-N 2-[6-[[2-[bis(2-hydroxyethyl)amino]-2-oxoethyl]-methylamino]-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(=O)N(CCO)CCO)C)C#N)CC)C#N)=O PWKQIYKPPHHUCG-UHFFFAOYSA-N 0.000 claims 2
- UDLKSJKVQWSPIW-UHFFFAOYSA-N 2-[[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]piperidin-3-yl]amino]acetic acid Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CC(CCC1)NCC(=O)O)C#N)C1CC1)C#N)=O UDLKSJKVQWSPIW-UHFFFAOYSA-N 0.000 claims 2
- FMPXFUQXHLFWGA-UHFFFAOYSA-N 2-[[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]amino]acetic acid Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)NCC(=O)O)C#N)CC)C#N)=O FMPXFUQXHLFWGA-UHFFFAOYSA-N 0.000 claims 2
- MQMOQJRQUDYHIT-UHFFFAOYSA-N 2-[[4-cyano-3-(1,4-diazepan-1-yl)-6,7-dihydro-5H-cyclopenta[c]pyridin-1-yl]sulfanyl]-2-phenylacetamide Chemical compound C(#N)C=1C2=C(C(=NC=1N1CCNCCC1)SC(C(=O)N)C1=CC=CC=C1)CCC2 MQMOQJRQUDYHIT-UHFFFAOYSA-N 0.000 claims 2
- IKVXIXHNROKJNB-UHFFFAOYSA-N 2-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]-methylamino]ethyl carbamate Chemical compound C(N)(OCCN(C)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)=O IKVXIXHNROKJNB-UHFFFAOYSA-N 0.000 claims 2
- MCEDGEJMPSOBJC-UHFFFAOYSA-N 2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-cyclopropylpyridin-2-yl]piperidin-4-yl]-2-methylpropanamide Chemical compound NC(C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)C1CC1)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C MCEDGEJMPSOBJC-UHFFFAOYSA-N 0.000 claims 2
- BRFPBSADPQNVNY-UHFFFAOYSA-N 2-amino-N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]-2-methylpropanamide Chemical compound NC(C(=O)NC1CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C BRFPBSADPQNVNY-UHFFFAOYSA-N 0.000 claims 2
- MTYKWTDQRMWOKT-UHFFFAOYSA-N 2-amino-N-[2-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]ethyl]-2-methylpropanamide Chemical compound NC(C(=O)NCCN(C)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C MTYKWTDQRMWOKT-UHFFFAOYSA-N 0.000 claims 2
- NDIYHVIIZPPWEE-OQHSHRKDSA-N 2-amino-N-[[(2R)-4-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]morpholin-2-yl]methyl]-2-methylpropanamide Chemical compound NC(C(=O)NC[C@@H]1CN(CCO1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C NDIYHVIIZPPWEE-OQHSHRKDSA-N 0.000 claims 2
- NDIYHVIIZPPWEE-PBVYKCSPSA-N 2-amino-N-[[(2S)-4-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]morpholin-2-yl]methyl]-2-methylpropanamide Chemical compound NC(C(=O)NC[C@H]1CN(CCO1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C NDIYHVIIZPPWEE-PBVYKCSPSA-N 0.000 claims 2
- PJISFTNPCBHBNK-LBOXEOMUSA-N 2-amino-N-[[(3S)-1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-3-yl]methyl]-2-methylpropanamide Chemical compound NC(C(=O)NC[C@H]1CN(CCC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(C)C PJISFTNPCBHBNK-LBOXEOMUSA-N 0.000 claims 2
- LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical compound NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 claims 2
- KINCARDDMQLNIL-UHFFFAOYSA-N 3-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]-2-hydroxy-2-methylpropanamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CC(C(=O)N)(C)O)C)C#N)CC)C#N)=O KINCARDDMQLNIL-UHFFFAOYSA-N 0.000 claims 2
- WEBHAPVDDKHLJW-UHFFFAOYSA-N 3-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]propanamide Chemical compound NC(C(SC1=C(C(=C(C(=N1)N(CCC(=O)N)C)C#N)CC)C#N)C1=CC=CC=C1)=O WEBHAPVDDKHLJW-UHFFFAOYSA-N 0.000 claims 2
- VXEACFIHCXTPDL-UHFFFAOYSA-N 4-[2-amino-1-[3,5-dicyano-6-(dimethylamino)-4-ethylpyridin-2-yl]sulfanyl-2-oxoethyl]benzamide Chemical compound NC(C(SC1=NC(=C(C(=C1C#N)CC)C#N)N(C)C)C1=CC=C(C(=O)N)C=C1)=O VXEACFIHCXTPDL-UHFFFAOYSA-N 0.000 claims 2
- NIAKRPGWCWLBBG-UHFFFAOYSA-N 4-amino-1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidine-4-carboxamide Chemical compound NC1(CCN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)C(=O)N NIAKRPGWCWLBBG-UHFFFAOYSA-N 0.000 claims 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 2
- CENZDQUQOPAJAS-UHFFFAOYSA-N C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC1=NNC(N1)=O)C)SC(C(=O)N)C1=CC=CC=C1 Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N(CC1=NNC(N1)=O)C)SC(C(=O)N)C1=CC=CC=C1 CENZDQUQOPAJAS-UHFFFAOYSA-N 0.000 claims 2
- SMXWQGIDIGGEGD-UHFFFAOYSA-N C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CN(C)C)SC(C(=O)N)C1=CC=CC=C1 Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CC(OCC1)CN(C)C)SC(C(=O)N)C1=CC=CC=C1 SMXWQGIDIGGEGD-UHFFFAOYSA-N 0.000 claims 2
- OECXPPLXPCZWBO-UHFFFAOYSA-N C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(CC(C)(C)C)C)SC(C(=O)N)C1=CC=CC=C1 Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1CCC(CC1)N(CC(C)(C)C)C)SC(C(=O)N)C1=CC=CC=C1 OECXPPLXPCZWBO-UHFFFAOYSA-N 0.000 claims 2
- XRWCHQASSTZBPG-QFADGXAASA-N C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=C(C=C1)F Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)N1C[C@H](CCC1)CNCC(C)(C)C)SC(C(=O)N)C1=CC=C(C=C1)F XRWCHQASSTZBPG-QFADGXAASA-N 0.000 claims 2
- 108010009540 DNA (Cytosine-5-)-Methyltransferase 1 Proteins 0.000 claims 2
- 102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 claims 2
- 206010016654 Fibrosis Diseases 0.000 claims 2
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 claims 2
- 206010020631 Hypergammaglobulinaemia benign monoclonal Diseases 0.000 claims 2
- 208000034578 Multiple myelomas Diseases 0.000 claims 2
- WRXBNJOISAZOIR-UHFFFAOYSA-N N'-[2-[[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]-methylamino]ethyl]oxamide Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N(CCNC(C(=O)N)=O)C)C#N)CC)C#N)=O WRXBNJOISAZOIR-UHFFFAOYSA-N 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 claims 2
- 125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 claims 2
- 210000000481 breast Anatomy 0.000 claims 2
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 230000007882 cirrhosis Effects 0.000 claims 2
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 229910052740 iodine Inorganic materials 0.000 claims 2
- 239000011630 iodine Substances 0.000 claims 2
- 210000002429 large intestine Anatomy 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 229940017219 methyl propionate Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 201000005328 monoclonal gammopathy of uncertain significance Diseases 0.000 claims 2
- DGOYLVBDCVINQZ-UHFFFAOYSA-N oxane-4-carboxamide Chemical compound NC(=O)C1CCOCC1 DGOYLVBDCVINQZ-UHFFFAOYSA-N 0.000 claims 2
- 125000002971 oxazolyl group Chemical group 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 125000006308 propyl amino group Chemical group 0.000 claims 2
- ZUCWGOUXHFRKCF-UHFFFAOYSA-N tert-butyl N-[1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]piperidin-4-yl]carbamate Chemical compound NC(C(C1=CC=CC=C1)SC1=C(C(=C(C(=N1)N1CCC(CC1)NC(OC(C)(C)C)=O)C#N)CC)C#N)=O ZUCWGOUXHFRKCF-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- FGQIKVMUUPNDOL-CQSZACIVSA-N (2r)-2-(6-amino-3,5-dicyano-4-ethylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound CCC1=C(C#N)C(N)=NC(S[C@@H](C(N)=O)C=2C=CC=CC=2)=C1C#N FGQIKVMUUPNDOL-CQSZACIVSA-N 0.000 claims 1
- VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 claims 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- BYIMTTMNMSKOFX-UHFFFAOYSA-N 2-(6-amino-3,5-dicyano-4-cyclopropylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound NC1=C(C(=C(C(=N1)SC(C(=O)N)C1=CC=CC=C1)C#N)C1CC1)C#N BYIMTTMNMSKOFX-UHFFFAOYSA-N 0.000 claims 1
- FGQIKVMUUPNDOL-UHFFFAOYSA-N 2-(6-amino-3,5-dicyano-4-ethylpyridin-2-yl)sulfanyl-2-phenylacetamide Chemical compound CCC1=C(C#N)C(N)=NC(SC(C(N)=O)C=2C=CC=CC=2)=C1C#N FGQIKVMUUPNDOL-UHFFFAOYSA-N 0.000 claims 1
- AYFHTZLGPLSXOL-UHFFFAOYSA-N 2-[3,5-dicyano-4-ethyl-6-(methylamino)pyridin-2-yl]sulfanyl-2-phenylacetamide Chemical compound C(#N)C=1C(=NC(=C(C=1CC)C#N)NC)SC(C(=O)N)C1=CC=CC=C1 AYFHTZLGPLSXOL-UHFFFAOYSA-N 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- NRPURYORSRHBCU-UHFFFAOYSA-N 5-oxa-2-azaspiro[3.4]octane Chemical compound C1NCC11OCCC1 NRPURYORSRHBCU-UHFFFAOYSA-N 0.000 claims 1
- DGGKXQQCVPAUEA-UHFFFAOYSA-N 8-azabicyclo[3.2.1]octane Chemical compound C1CCC2CCC1N2 DGGKXQQCVPAUEA-UHFFFAOYSA-N 0.000 claims 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000032467 Aplastic anaemia Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000011691 Burkitt lymphomas Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 229940123780 DNA topoisomerase I inhibitor Drugs 0.000 claims 1
- 229940124087 DNA topoisomerase II inhibitor Drugs 0.000 claims 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 1
- 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 206010014967 Ependymoma Diseases 0.000 claims 1
- 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 claims 1
- 208000036566 Erythroleukaemia Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 208000006168 Ewing Sarcoma Diseases 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 claims 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 208000005726 Inflammatory Breast Neoplasms Diseases 0.000 claims 1
- 206010021980 Inflammatory carcinoma of the breast Diseases 0.000 claims 1
- 208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 208000000265 Lobular Carcinoma Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000000172 Medulloblastoma Diseases 0.000 claims 1
- 208000035490 Megakaryoblastic Acute Leukemia Diseases 0.000 claims 1
- 206010027145 Melanocytic naevus Diseases 0.000 claims 1
- 206010027406 Mesothelioma Diseases 0.000 claims 1
- 206010027480 Metastatic malignant melanoma Diseases 0.000 claims 1
- 229940122255 Microtubule inhibitor Drugs 0.000 claims 1
- 208000003445 Mouth Neoplasms Diseases 0.000 claims 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 206010052399 Neuroendocrine tumour Diseases 0.000 claims 1
- 208000007256 Nevus Diseases 0.000 claims 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 229940124060 PD-1 antagonist Drugs 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000007452 Plasmacytoma Diseases 0.000 claims 1
- 229940079156 Proteasome inhibitor Drugs 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000004337 Salivary Gland Neoplasms Diseases 0.000 claims 1
- 206010061934 Salivary gland cancer Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 206010042971 T-cell lymphoma Diseases 0.000 claims 1
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 206010057644 Testis cancer Diseases 0.000 claims 1
- 102100039360 Toll-like receptor 4 Human genes 0.000 claims 1
- 239000000365 Topoisomerase I Inhibitor Substances 0.000 claims 1
- 239000000317 Topoisomerase II Inhibitor Substances 0.000 claims 1
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 1
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 206010047741 Vulval cancer Diseases 0.000 claims 1
- 208000004354 Vulvar Neoplasms Diseases 0.000 claims 1
- 208000008383 Wilms tumor Diseases 0.000 claims 1
- GNNQKWGCFDPRQZ-UHFFFAOYSA-N [1-[6-(2-amino-2-oxo-1-phenylethyl)sulfanyl-3,5-dicyano-4-ethylpyridin-2-yl]pyrrolidin-3-yl] dihydrogen phosphate Chemical compound P(=O)(OC1CN(CC1)C1=NC(=C(C(=C1C#N)CC)C#N)SC(C(=O)N)C1=CC=CC=C1)(O)O GNNQKWGCFDPRQZ-UHFFFAOYSA-N 0.000 claims 1
- 208000021841 acute erythroid leukemia Diseases 0.000 claims 1
- 208000037833 acute lymphoblastic T-cell leukemia Diseases 0.000 claims 1
- 208000013593 acute megakaryoblastic leukemia Diseases 0.000 claims 1
- 208000020700 acute megakaryocytic leukemia Diseases 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 239000004037 angiogenesis inhibitor Substances 0.000 claims 1
- 229940121369 angiogenesis inhibitor Drugs 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000000340 anti-metabolite Effects 0.000 claims 1
- 230000000118 anti-neoplastic effect Effects 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940100197 antimetabolite Drugs 0.000 claims 1
- 239000002256 antimetabolite Substances 0.000 claims 1
- 229940034982 antineoplastic agent Drugs 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 208000005980 beta thalassemia Diseases 0.000 claims 1
- 201000011143 bone giant cell tumor Diseases 0.000 claims 1
- 201000003714 breast lobular carcinoma Diseases 0.000 claims 1
- 230000022131 cell cycle Effects 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000033679 diabetic kidney disease Diseases 0.000 claims 1
- 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 208000028715 ductal breast carcinoma in situ Diseases 0.000 claims 1
- 210000003038 endothelium Anatomy 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 201000003444 follicular lymphoma Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 210000004907 gland Anatomy 0.000 claims 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 1
- 201000009277 hairy cell leukemia Diseases 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 210000003494 hepatocyte Anatomy 0.000 claims 1
- 125000004404 heteroalkyl group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims 1
- 239000002944 hormone and hormone analog Substances 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 239000002955 immunomodulating agent Substances 0.000 claims 1
- 201000004653 inflammatory breast carcinoma Diseases 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 206010073096 invasive lobular breast carcinoma Diseases 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 208000003849 large cell carcinoma Diseases 0.000 claims 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000003747 lymphoid leukemia Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 208000021039 metastatic melanoma Diseases 0.000 claims 1
- 231100000782 microtubule inhibitor Toxicity 0.000 claims 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 claims 1
- 201000008026 nephroblastoma Diseases 0.000 claims 1
- 208000016065 neuroendocrine neoplasm Diseases 0.000 claims 1
- 201000011519 neuroendocrine tumor Diseases 0.000 claims 1
- 210000000440 neutrophil Anatomy 0.000 claims 1
- 102000037979 non-receptor tyrosine kinases Human genes 0.000 claims 1
- 108091008046 non-receptor tyrosine kinases Proteins 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 201000008968 osteosarcoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 230000037361 pathway Effects 0.000 claims 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 1
- 229910052697 platinum Inorganic materials 0.000 claims 1
- 210000000557 podocyte Anatomy 0.000 claims 1
- 208000014081 polyp of colon Diseases 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 239000003207 proteasome inhibitor Substances 0.000 claims 1
- 239000000296 purinergic P1 receptor antagonist Substances 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 230000019491 signal transduction Effects 0.000 claims 1
- 230000011664 signaling Effects 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 206010044412 transitional cell carcinoma Diseases 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 201000005102 vulva cancer Diseases 0.000 claims 1
- 0 C*c(nc1*)c(*)c(*)c1C#N Chemical compound C*c(nc1*)c(*)c(*)c1C#N 0.000 description 2
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662349227P | 2016-06-13 | 2016-06-13 | |
| US62/349,227 | 2016-06-13 | ||
| US201662393256P | 2016-09-12 | 2016-09-12 | |
| US62/393,256 | 2016-09-12 | ||
| US201662412343P | 2016-10-25 | 2016-10-25 | |
| US62/412,343 | 2016-10-25 | ||
| PCT/IB2017/053511 WO2017216727A1 (en) | 2016-06-13 | 2017-06-13 | Substituted pyridines as inhibitors of dnmt1 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019517596A JP2019517596A (ja) | 2019-06-24 |
| JP2019517596A5 true JP2019517596A5 (enExample) | 2020-07-27 |
| JP7051829B2 JP7051829B2 (ja) | 2022-04-11 |
Family
ID=59239935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517187A Active JP7051829B2 (ja) | 2016-06-13 | 2017-06-13 | Dnmt1の阻害剤としての置換ピリジン |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10975056B2 (enExample) |
| EP (1) | EP3468953B1 (enExample) |
| JP (1) | JP7051829B2 (enExample) |
| KR (1) | KR20190017030A (enExample) |
| CN (1) | CN109563043B (enExample) |
| AU (1) | AU2017283790B2 (enExample) |
| CA (2) | CA3026226A1 (enExample) |
| CL (1) | CL2018003577A1 (enExample) |
| CO (1) | CO2018013717A2 (enExample) |
| CR (1) | CR20180580A (enExample) |
| DO (1) | DOP2018000273A (enExample) |
| ES (1) | ES2993451T3 (enExample) |
| IL (1) | IL263163B (enExample) |
| JO (1) | JOP20180120A1 (enExample) |
| MA (1) | MA45244A (enExample) |
| MX (1) | MX391600B (enExample) |
| PE (1) | PE20190971A1 (enExample) |
| PH (1) | PH12018502633B1 (enExample) |
| SG (1) | SG11201809559UA (enExample) |
| WO (2) | WO2017216727A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA034786B1 (ru) | 2015-08-13 | 2020-03-20 | Мерк Шарп И Доум Корп. | Циклические динуклеотидные соединения в качестве агонистов sting |
| US11453697B1 (en) | 2015-08-13 | 2022-09-27 | Merck Sharp & Dohme Llc | Cyclic di-nucleotide compounds as sting agonists |
| SI3730487T1 (sl) | 2016-06-13 | 2022-08-31 | Gilead Sciences, Inc. | Azetidinski derivati kot modulatorji FXR (NR1H4) |
| CA3252823A1 (en) | 2016-06-13 | 2025-02-25 | Gilead Sciences Inc | Fxr (nr1h4) modulating compounds |
| TN2020000158A1 (en) | 2016-10-04 | 2022-04-04 | Merck Sharp & Dohme | BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS |
| JP6906626B2 (ja) | 2017-03-28 | 2021-07-21 | ギリアード サイエンシーズ, インコーポレイテッド | 肝疾患を処置するための治療的組み合わせ |
| EP3621624B1 (en) | 2017-05-12 | 2023-08-30 | Merck Sharp & Dohme LLC | Cyclic di-nucleotide compounds as sting agonists |
| US11285131B2 (en) | 2017-08-04 | 2022-03-29 | Merck Sharp & Dohme Corp. | Benzo[b]thiophene STING agonists for cancer treatment |
| RU2020109328A (ru) | 2017-08-04 | 2021-09-06 | Мерк Шарп И Доум Корп. | Комбинации антагонистов pd-1 и бензо[b]тиофеновых агонистов sting для лечения рака |
| CN109651358B (zh) * | 2017-10-11 | 2023-04-07 | 上海迪诺医药科技有限公司 | 4-氨基吡啶衍生物、其药物组合物、制备方法及应用 |
| WO2019125974A1 (en) | 2017-12-20 | 2019-06-27 | Merck Sharp & Dohme Corp. | Cyclic di-nucleotide compounds as sting agonists |
| WO2019195124A1 (en) | 2018-04-03 | 2019-10-10 | Merck Sharp & Dohme Corp. | Benzothiophenes and related compounds as sting agonists |
| WO2019195063A1 (en) | 2018-04-03 | 2019-10-10 | Merck Sharp & Dohme Corp. | Aza-benzothiophene compounds as sting agonists |
| US11225473B2 (en) | 2019-01-15 | 2022-01-18 | Gilead Sciences, Inc. | FXR (NR1H4) modulating compounds |
| EP3927683A1 (en) | 2019-02-19 | 2021-12-29 | Gilead Sciences, Inc. | Solid forms of fxr agonists |
| CN113480541B (zh) * | 2019-03-07 | 2022-09-02 | 湖南化工研究院有限公司 | 咪唑并吡啶化合物及其中间体的制备方法 |
| WO2022076563A1 (en) * | 2020-10-07 | 2022-04-14 | University Of Florida Research Foundation, Incorporated | Macrocyclic compounds and methods of treatment |
| PH12023552345A1 (en) * | 2021-03-02 | 2024-04-22 | Glaxosmithkline Ip Dev Ltd | Substituted pyridines as dnmt1 inhibitors |
| CN113502265B (zh) * | 2021-05-25 | 2024-05-28 | 昭泰英基生物医药(香港)有限公司 | 将t细胞重编程为类nk细胞的诱导剂及其应用 |
| CN113278021B (zh) * | 2021-05-29 | 2022-09-23 | 天津全和诚科技有限责任公司 | 1,7-二氮杂螺[3.5]壬烷-7-甲酸叔丁酯及其草酸盐的制备方法 |
| AU2022370354A1 (en) | 2021-10-19 | 2024-05-30 | Akirabio, Inc. | Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancers |
| CN114230459A (zh) * | 2021-12-10 | 2022-03-25 | 武汉九州钰民医药科技有限公司 | 一种化合物的制备方法及分析检测方法 |
| WO2023192629A1 (en) * | 2022-04-01 | 2023-10-05 | Herophilus, Inc. | Induction of mecp2 expression by dna methyl transferase inhibitors |
| WO2024156288A1 (en) * | 2023-01-29 | 2024-08-02 | Shanghai Kygent Pharmaceutical Co., Ltd | Dnmt1 inhibitors, pharmaceutical compositions, and therapeutic applications |
| WO2025006902A2 (en) * | 2023-06-29 | 2025-01-02 | Dana-Farber Cancer Institute, Inc. | Synthesis and in vitro characterization of proteolysis targeting chimeras (protacs) for degradation of dna methyltransferase 1 (dnmt1) |
| WO2025085756A1 (en) * | 2023-10-18 | 2025-04-24 | University Of Florida Research Foundation, Incorporated | Macrocyclic compounds and methods of treatment |
| WO2025190285A1 (en) * | 2024-03-12 | 2025-09-18 | Shanghai Kygent Pharmaceutical Co., Ltd | Pyridine compounds, pharmaceutical compositions, and applications |
| CN119306700A (zh) * | 2024-08-28 | 2025-01-14 | 山东大学 | Dnmt1-hdac双靶点抑制剂及其制备方法和应用 |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2030875C (en) | 1990-11-26 | 2002-07-02 | Alan R.P. Paterson | Methods and probes for detecting nucleoside transporter and method for producing the probes |
| CA2075154A1 (en) | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
| ZA942125B (en) | 1993-03-26 | 1994-11-10 | Shell Res Ltd | Herbicidal heterocyclic compounds. |
| CZ203798A3 (cs) | 1995-12-29 | 1998-12-16 | Smithkline Beecham Corporation | Antagonista vitronektinového receptoru, farmaceutický přípravek s jeho obsahem, způsob a použití |
| AU1295597A (en) | 1995-12-29 | 1997-07-28 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| DE19947154A1 (de) * | 1999-10-01 | 2001-10-04 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| EP1242366A1 (en) | 1999-12-15 | 2002-09-25 | Axys Pharmaceuticals, Inc. | Salicylamides as serine protease and factor xa inhibitors |
| US6794506B2 (en) | 2000-07-21 | 2004-09-21 | Elan Pharmaceuticals, Inc. | 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| US20030166554A1 (en) | 2001-01-16 | 2003-09-04 | Genset, S.A. | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| DE10110754A1 (de) * | 2001-03-07 | 2002-09-19 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| DE10134481A1 (de) * | 2001-07-16 | 2003-01-30 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
| DE10238113A1 (de) * | 2001-12-11 | 2003-06-18 | Bayer Ag | Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung |
| TW200406370A (en) | 2002-06-28 | 2004-05-01 | Syngenta Participations Ag | 4-(3,3-Dihalo-allyloxy)phenoxy alkyl derivatives |
| TW200406152A (en) | 2002-08-30 | 2004-05-01 | Syngenta Participations Ag | 4-(3,3-Dihalo-allyloxy) phenol derivatives having pesticidal properties |
| US6930117B2 (en) | 2002-11-09 | 2005-08-16 | The Procter & Gamble Company | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| AR042344A1 (es) | 2002-12-11 | 2005-06-15 | Syngenta Participations Ag | Derivados de 4-(3,3 - dihalo - aliloxi) fenol con propiedades pesticidas |
| SE0203712D0 (sv) | 2002-12-13 | 2002-12-13 | Astrazeneca Ab | Novel compounds |
| CA2520323C (en) | 2003-04-09 | 2013-07-09 | Exelixis, Inc. | Tie-2 modulators and methods of use |
| WO2004103954A1 (ja) | 2003-05-20 | 2004-12-02 | Ajinomoto Co., Inc. | アミド誘導体 |
| CN1856307A (zh) | 2003-09-23 | 2006-11-01 | 默克公司 | 喹啉钾通道抑制剂 |
| AU2011253934C1 (en) | 2004-06-17 | 2013-08-22 | Cytokinetics, Inc. | Substituted urea derivatives for treating cardiac diseases |
| US7776869B2 (en) | 2004-10-18 | 2010-08-17 | Amgen Inc. | Heteroaryl-substituted alkyne compounds and method of use |
| EP1655296A1 (en) | 2004-10-25 | 2006-05-10 | Graffinity Pharmaceuticals AG | Thrombin inhibitors |
| WO2006078752A2 (en) | 2005-01-21 | 2006-07-27 | Methylgene, Inc. | Inhibitors of dna methyltransferase |
| GB0517740D0 (en) | 2005-08-31 | 2005-10-12 | Novartis Ag | Organic compounds |
| US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| EP2030971B1 (en) | 2006-06-20 | 2011-10-12 | Ishihara Sangyo Kaisha, Ltd. | Pest control agent containing novel pyridyl-methanamine derivative or salt thereof |
| US20080132525A1 (en) | 2006-12-04 | 2008-06-05 | Methylgene Inc. | Inhibitors of DNA Methyltransferase |
| AU2008211729A1 (en) | 2007-02-01 | 2008-08-07 | Astrazeneca Ab | 5,6,7,8-tetrahydropteridine derivatives as HSP90 inhibitors |
| US20090011994A1 (en) | 2007-07-06 | 2009-01-08 | Bristol-Myers Squibb Company | Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| WO2009034433A2 (en) | 2007-09-10 | 2009-03-19 | Glenmark Pharmaceuticals, S.A. | 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands |
| ES2446932T3 (es) | 2007-10-08 | 2014-03-10 | Advinus Therapeutics Private Limited | Derivados de acetamida como activadores de glucoquinasa, su procedimiento y aplicaciones en medicina |
| US8343966B2 (en) | 2008-01-11 | 2013-01-01 | Novartis Ag | Organic compounds |
| UY31952A (es) | 2008-07-02 | 2010-01-29 | Astrazeneca Ab | 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim |
| WO2010007756A1 (ja) * | 2008-07-14 | 2010-01-21 | 塩野義製薬株式会社 | Ttk阻害作用を有するピリジン誘導体 |
| UY32055A (es) | 2008-08-19 | 2010-03-26 | Astrazeneca Ab | Derivados sustituidos de la 5-Halo-N2-[sustituido](1-metil-1H-imidazol-4-il)pirimidin-2,-diamina y sus sales farmacéuticamente aceptables, procesos de preparación, composiciones y aplicaciones. |
| WO2010048149A2 (en) | 2008-10-20 | 2010-04-29 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| AR074760A1 (es) | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
| WO2010088518A2 (en) | 2009-01-31 | 2010-08-05 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| KR101146010B1 (ko) * | 2009-09-10 | 2012-05-16 | 서울대학교산학협력단 | TNF-α 매개성 질환의 예방 및 치료용 조성물 |
| US20120238557A1 (en) | 2009-11-13 | 2012-09-20 | Shionogi & Co., Ltd. | Aminothiazine or aminooxazine derivative having amino linker |
| KR101790255B1 (ko) | 2009-12-23 | 2017-10-26 | 다케다 야쿠힌 고교 가부시키가이샤 | Syk 억제제로서의 융합된 헤테로방향족 피롤리디논 |
| CN102884062B (zh) | 2009-12-23 | 2016-08-03 | 嘉世高制药公司 | 氨基嘧啶激酶抑制剂 |
| EP2338888A1 (en) | 2009-12-24 | 2011-06-29 | Almirall, S.A. | Imidazopyridine derivatives as JAK inhibitors |
| WO2011103289A2 (en) | 2010-02-17 | 2011-08-25 | Jasco Pharmaceuticals, LLC | Imidazole-2, 4-dione inhibitors of casein kinase 1 |
| WO2011150156A2 (en) | 2010-05-26 | 2011-12-01 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| WO2012040636A2 (en) | 2010-09-24 | 2012-03-29 | The Broad Institute, Inc. | Compounds and methods for treating diseases mediated by protease activated receptors |
| US20120184572A1 (en) | 2011-01-13 | 2012-07-19 | Metabolex, Inc. | Aryl gpr119 agonists and uses thereof |
| CA2824808A1 (en) | 2011-01-17 | 2012-07-26 | Karyopharm Therapeutics, Inc. | Olefin containing nuclear transport modulators and uses thereof |
| WO2012170931A2 (en) | 2011-06-10 | 2012-12-13 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| WO2013019635A1 (en) | 2011-07-29 | 2013-02-07 | Tempero Pharmaceuticals, Inc. | Compounds and methods |
| WO2013019621A1 (en) | 2011-07-29 | 2013-02-07 | Tempero Pharmaceuticals, Inc. | Compounds and methods |
| EP2771012A4 (en) * | 2011-10-24 | 2015-06-24 | Glaxosmithkline Ip No 2 Ltd | NEW CONNECTIONS |
| US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
| NZ706857A (en) | 2012-09-28 | 2018-05-25 | Ignyta Inc | Azaquinazoline inhibitors of atypical protein kinase c |
| JP2017502968A (ja) | 2014-01-21 | 2017-01-26 | ウォックハート リミテッド | 7−オキソ−1,6−ジアザビシクロ[3.2.1]オクタン誘導体及び抗菌剤としてのその使用 |
| WO2015110999A1 (en) | 2014-01-24 | 2015-07-30 | Piramal Enterprises Limited | Ezh2 inhibitors and uses thereof |
-
2017
- 2017-06-13 CA CA3026226A patent/CA3026226A1/en not_active Abandoned
- 2017-06-13 MX MX2018015483A patent/MX391600B/es unknown
- 2017-06-13 EP EP17733902.5A patent/EP3468953B1/en active Active
- 2017-06-13 PH PH1/2018/502633A patent/PH12018502633B1/en unknown
- 2017-06-13 MA MA045244A patent/MA45244A/fr unknown
- 2017-06-13 US US16/309,121 patent/US10975056B2/en active Active
- 2017-06-13 SG SG11201809559UA patent/SG11201809559UA/en unknown
- 2017-06-13 AU AU2017283790A patent/AU2017283790B2/en not_active Ceased
- 2017-06-13 CA CA3026211A patent/CA3026211A1/en active Pending
- 2017-06-13 WO PCT/IB2017/053511 patent/WO2017216727A1/en not_active Ceased
- 2017-06-13 WO PCT/IB2017/053509 patent/WO2017216726A1/en not_active Ceased
- 2017-06-13 KR KR1020197000766A patent/KR20190017030A/ko not_active Ceased
- 2017-06-13 CR CR20180580A patent/CR20180580A/es unknown
- 2017-06-13 JP JP2019517187A patent/JP7051829B2/ja active Active
- 2017-06-13 PE PE2018003216A patent/PE20190971A1/es unknown
- 2017-06-13 ES ES17733902T patent/ES2993451T3/es active Active
- 2017-06-13 CN CN201780036908.XA patent/CN109563043B/zh active Active
-
2018
- 2018-11-21 IL IL263163A patent/IL263163B/en unknown
- 2018-12-07 DO DO2018000273A patent/DOP2018000273A/es unknown
- 2018-12-10 JO JOP/2018/0120A patent/JOP20180120A1/ar unknown
- 2018-12-12 CL CL2018003577A patent/CL2018003577A1/es unknown
- 2018-12-18 CO CONC2018/0013717A patent/CO2018013717A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019517596A5 (enExample) | ||
| JP7216682B2 (ja) | Usp30阻害剤としての1-シアノ-ピロリジン化合物 | |
| ES2727376T3 (es) | Derivados de aminotriazina útiles como compuestos inhibidores de quinasa de unión TANK | |
| US12071428B2 (en) | Indazole compounds as kinase inhibitors | |
| ES3004042T3 (en) | Fused ring compounds | |
| ES2523892T3 (es) | Derivados triazol y utilización de los mismos para trastornos neurológicos | |
| CN102112467B (zh) | 作为激酶抑制剂的嘧啶衍生物 | |
| ES2715325T3 (es) | Derivados de 6-bencilo-6H-pirido[3.2-e][1.2.4]triazolo[1,5-c]pirimidina-5-ona y 6-bencilo-[1.2.4]triazolo[1,5-c]pteridina-5(6H)-ona como inhibidores de PDE1 para el tratamiento, p. ej. trastornos neurológicos | |
| HRP20240293T1 (hr) | Derivati kinazolina kao protutumorska sredstva | |
| JP2010512338A5 (enExample) | ||
| CN108430993A (zh) | Tank-结合激酶抑制剂化合物 | |
| KR20190091537A (ko) | C-kit 억제제로서의 아미노티아졸 화합물 | |
| JP2017530999A5 (enExample) | ||
| AU2010286569A1 (en) | Compounds and compositions as protein kinase inhibitors | |
| JP2019508384A (ja) | 5−置換2−(モルホリン−4−イル)−1,7−ナフチリジン | |
| CN101605540A (zh) | 使用mek抑制剂的方法 | |
| JP2017532360A5 (enExample) | ||
| AU2016270373A1 (en) | Triazoles for the treatment of demyelinating diseases | |
| RU2017118165A (ru) | Ингибиторы энхансера гомолога 2 zestes | |
| JPWO2020057511A5 (enExample) | ||
| WO2017157792A1 (en) | Combinations of copanlisib | |
| KR20250121029A (ko) | 두드러기 치료를 위한 야생형 c-kit 키나제 억제제로서의 n-페닐-피라졸로[1,5-a]피리딘-3-카르복사미드 유도체 | |
| WO2020203610A1 (ja) | 関節リウマチを治療するためのt型カルシウムチャネル阻害剤の使用 | |
| JP7651590B2 (ja) | アミノピリミジン誘導体およびアリール炭化水素受容体モジュレーターとしてのその使用 | |
| JP2024511841A (ja) | 置換された1-アリール-1’-ヘテロアリール化合物、置換された1,1’-ビヘテロアリール化合物、及びこれらを使用する方法 |